% Options for packages loaded elsewhere
\PassOptionsToPackage{unicode}{hyperref}
\PassOptionsToPackage{hyphens}{url}
%
\documentclass[
]{book}
\usepackage{lmodern}
\usepackage{amssymb,amsmath}
\usepackage{ifxetex,ifluatex}
\ifnum 0\ifxetex 1\fi\ifluatex 1\fi=0 % if pdftex
  \usepackage[T1]{fontenc}
  \usepackage[utf8]{inputenc}
  \usepackage{textcomp} % provide euro and other symbols
\else % if luatex or xetex
  \usepackage{unicode-math}
  \defaultfontfeatures{Scale=MatchLowercase}
  \defaultfontfeatures[\rmfamily]{Ligatures=TeX,Scale=1}
\fi
% Use upquote if available, for straight quotes in verbatim environments
\IfFileExists{upquote.sty}{\usepackage{upquote}}{}
\IfFileExists{microtype.sty}{% use microtype if available
  \usepackage[]{microtype}
  \UseMicrotypeSet[protrusion]{basicmath} % disable protrusion for tt fonts
}{}
\makeatletter
\@ifundefined{KOMAClassName}{% if non-KOMA class
  \IfFileExists{parskip.sty}{%
    \usepackage{parskip}
  }{% else
    \setlength{\parindent}{0pt}
    \setlength{\parskip}{6pt plus 2pt minus 1pt}}
}{% if KOMA class
  \KOMAoptions{parskip=half}}
\makeatother
\usepackage{xcolor}
\IfFileExists{xurl.sty}{\usepackage{xurl}}{} % add URL line breaks if available
\IfFileExists{bookmark.sty}{\usepackage{bookmark}}{\usepackage{hyperref}}
\hypersetup{
  pdftitle={A concise guide to reproducible research using secondary data},
  pdfauthor={Katharina Blankart, Maryna Ivets, Eva Goetjes, Kai Miele},
  hidelinks,
  pdfcreator={LaTeX via pandoc}}
\urlstyle{same} % disable monospaced font for URLs
\usepackage{color}
\usepackage{fancyvrb}
\newcommand{\VerbBar}{|}
\newcommand{\VERB}{\Verb[commandchars=\\\{\}]}
\DefineVerbatimEnvironment{Highlighting}{Verbatim}{commandchars=\\\{\}}
% Add ',fontsize=\small' for more characters per line
\usepackage{framed}
\definecolor{shadecolor}{RGB}{248,248,248}
\newenvironment{Shaded}{\begin{snugshade}}{\end{snugshade}}
\newcommand{\AlertTok}[1]{\textcolor[rgb]{0.94,0.16,0.16}{#1}}
\newcommand{\AnnotationTok}[1]{\textcolor[rgb]{0.56,0.35,0.01}{\textbf{\textit{#1}}}}
\newcommand{\AttributeTok}[1]{\textcolor[rgb]{0.77,0.63,0.00}{#1}}
\newcommand{\BaseNTok}[1]{\textcolor[rgb]{0.00,0.00,0.81}{#1}}
\newcommand{\BuiltInTok}[1]{#1}
\newcommand{\CharTok}[1]{\textcolor[rgb]{0.31,0.60,0.02}{#1}}
\newcommand{\CommentTok}[1]{\textcolor[rgb]{0.56,0.35,0.01}{\textit{#1}}}
\newcommand{\CommentVarTok}[1]{\textcolor[rgb]{0.56,0.35,0.01}{\textbf{\textit{#1}}}}
\newcommand{\ConstantTok}[1]{\textcolor[rgb]{0.00,0.00,0.00}{#1}}
\newcommand{\ControlFlowTok}[1]{\textcolor[rgb]{0.13,0.29,0.53}{\textbf{#1}}}
\newcommand{\DataTypeTok}[1]{\textcolor[rgb]{0.13,0.29,0.53}{#1}}
\newcommand{\DecValTok}[1]{\textcolor[rgb]{0.00,0.00,0.81}{#1}}
\newcommand{\DocumentationTok}[1]{\textcolor[rgb]{0.56,0.35,0.01}{\textbf{\textit{#1}}}}
\newcommand{\ErrorTok}[1]{\textcolor[rgb]{0.64,0.00,0.00}{\textbf{#1}}}
\newcommand{\ExtensionTok}[1]{#1}
\newcommand{\FloatTok}[1]{\textcolor[rgb]{0.00,0.00,0.81}{#1}}
\newcommand{\FunctionTok}[1]{\textcolor[rgb]{0.00,0.00,0.00}{#1}}
\newcommand{\ImportTok}[1]{#1}
\newcommand{\InformationTok}[1]{\textcolor[rgb]{0.56,0.35,0.01}{\textbf{\textit{#1}}}}
\newcommand{\KeywordTok}[1]{\textcolor[rgb]{0.13,0.29,0.53}{\textbf{#1}}}
\newcommand{\NormalTok}[1]{#1}
\newcommand{\OperatorTok}[1]{\textcolor[rgb]{0.81,0.36,0.00}{\textbf{#1}}}
\newcommand{\OtherTok}[1]{\textcolor[rgb]{0.56,0.35,0.01}{#1}}
\newcommand{\PreprocessorTok}[1]{\textcolor[rgb]{0.56,0.35,0.01}{\textit{#1}}}
\newcommand{\RegionMarkerTok}[1]{#1}
\newcommand{\SpecialCharTok}[1]{\textcolor[rgb]{0.00,0.00,0.00}{#1}}
\newcommand{\SpecialStringTok}[1]{\textcolor[rgb]{0.31,0.60,0.02}{#1}}
\newcommand{\StringTok}[1]{\textcolor[rgb]{0.31,0.60,0.02}{#1}}
\newcommand{\VariableTok}[1]{\textcolor[rgb]{0.00,0.00,0.00}{#1}}
\newcommand{\VerbatimStringTok}[1]{\textcolor[rgb]{0.31,0.60,0.02}{#1}}
\newcommand{\WarningTok}[1]{\textcolor[rgb]{0.56,0.35,0.01}{\textbf{\textit{#1}}}}
\usepackage{longtable,booktabs}
% Correct order of tables after \paragraph or \subparagraph
\usepackage{etoolbox}
\makeatletter
\patchcmd\longtable{\par}{\if@noskipsec\mbox{}\fi\par}{}{}
\makeatother
% Allow footnotes in longtable head/foot
\IfFileExists{footnotehyper.sty}{\usepackage{footnotehyper}}{\usepackage{footnote}}
\makesavenoteenv{longtable}
\usepackage{graphicx,grffile}
\makeatletter
\def\maxwidth{\ifdim\Gin@nat@width>\linewidth\linewidth\else\Gin@nat@width\fi}
\def\maxheight{\ifdim\Gin@nat@height>\textheight\textheight\else\Gin@nat@height\fi}
\makeatother
% Scale images if necessary, so that they will not overflow the page
% margins by default, and it is still possible to overwrite the defaults
% using explicit options in \includegraphics[width, height, ...]{}
\setkeys{Gin}{width=\maxwidth,height=\maxheight,keepaspectratio}
% Set default figure placement to htbp
\makeatletter
\def\fps@figure{htbp}
\makeatother
\setlength{\emergencystretch}{3em} % prevent overfull lines
\providecommand{\tightlist}{%
  \setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}
\setcounter{secnumdepth}{-\maxdimen} % remove section numbering

\title{A concise guide to reproducible research using secondary data}
\author{Katharina Blankart, Maryna Ivets, Eva Goetjes, Kai Miele}
\date{2022-03-02}

\begin{document}
\frontmatter
\maketitle

\mainmatter
\hypertarget{a-study-guide-to-empirical-research-in-economics-and-management-using-secondary-data}{%
\chapter*{A study guide to empirical research in economics and
management using secondary
data}\label{a-study-guide-to-empirical-research-in-economics-and-management-using-secondary-data}}
\addcontentsline{toc}{chapter}{A study guide to empirical research in
economics and management using secondary data}

\hypertarget{objective}{%
\section*{Objective}\label{objective}}
\addcontentsline{toc}{section}{Objective}

This study guide is a resource for graduate students, PhD candidates,
and researchers performing applied empirical research in economics and
management sciences. The guide is meant for the field of analysis of
health care markets using secondary data. Many textbook examples use
readily available datasets for analysis of econometric problems. For
students developing a related research question and generating their own
analysis dataset, important steps that lead to a final analysis dataset
are often missing. Additionally, many resources focus on labor economics
problems. Resources that showcase processing and generating secondary
data are scarce. One reason is that data sources used in health care
applications are often subject to confidentiality and data protection
issues.

This guide explains the five essential steps needed to create a
reproducible research project. We introduce important terminology,
highlight relevant tasks, and provide key resources in the form of
textbooks and websites available via open access. We provide a concise
guide that users can easily access when starting academic research. Each
section takes about 10 to 15 minutes to read. We do not cover any
specific data science or econometric method, but point to the relevant
resources.

To use this guide most efficiently, users are required to have basic
knowledge in statistics, econometrics and program evaluation methods.
Users should be familiar with one essential programming language and one
major statistical package such as R or Stata. For maximum benefit
readers should have background knowledge and a research idea in mind for
their own reproducible project.

\hypertarget{learning-objectives}{%
\section*{Learning objectives}\label{learning-objectives}}
\addcontentsline{toc}{section}{Learning objectives}

The goal is to set up and carry out a data science project using
secondary data. Students will learn all steps starting with hypothesis
formulation, data generation and analysis, and presentation of empirical
results.

After reading and applying the principles introduced in this study
guide, you will be able to:

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\tightlist
\item
  Recognize the features of using secondary (health care) data in
  empirical research.
\item
  Execute the steps of a reproducible research project.
\item
  Implement an empirical research project.
\item
  Recall the steps taken to execute a reproducible research project
  using secondary data.
\end{enumerate}

\hypertarget{structure-of-the-study-guide}{%
\section*{Structure of the study
guide}\label{structure-of-the-study-guide}}
\addcontentsline{toc}{section}{Structure of the study guide}

The study guide consists of five chapters that include the essential
steps of a reproducible research project. Each step is covered in three
parts.

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\tightlist
\item
  An introduction to the basic concepts and key terminology.
\item
  A resources box that includes textbooks, articles and references to
  current web resources with emphasis on open access material.
\item
  A showcase example of an empirical project replicated based on the
  article of \emph{Hellerstein, Judith K. 1998. ``The Importance of the
  Physician in the Generic versus Trade-Name Prescription Decision.''
  The RAND Journal of Economics 29 (1): 108--36.
  \url{https://doi.org/10.2307/2555818}}.
\end{enumerate}

\hypertarget{this-is-a-living-document}{%
\section*{This is a living document}\label{this-is-a-living-document}}
\addcontentsline{toc}{section}{This is a living document}

How can you contribute to this study guide? Best practices how to
perform reproducible research are constantly developing. We aim to keep
resources up to date. If you come across good resources that serve as
additions, preferably open access, or have suggestions for improvement,
please share them by emailing to:
\href{mailto:katharina.blankart@uni-due.de}{\nolinkurl{katharina.blankart@uni-due.de}}

\hypertarget{about-the-authors}{%
\chapter*{About the authors}\label{about-the-authors}}
\addcontentsline{toc}{chapter}{About the authors}

\emph{Katharina Blankart} is an assistant professor in empirical health
economics at the Faculty of Economics and Business Administration at the
University of Duisburg-Essen and CINCH Health Economics Research Center.
Katharina is an economist with a PhD in Business Administration (both
Ludwig-Maximilians University Munich, Germany). Her research studies the
institutional settings of determining value of and access to health
technology. An important aspect of this research is how providers and
patients use technology to improve health and health care. Katharina's
research emphasizes the health policies and management of pharmaceutical
care using secondary data.

\emph{Maryna Ivets} {[}\ldots{} please fill in{]}

\emph{Eva Goetjes} {[}\ldots{} please fill in{]}

\emph{Kai Miele} {[}\ldots{} please fill in{]}

\hypertarget{acknowledgements}{%
\chapter*{Acknowledgements}\label{acknowledgements}}
\addcontentsline{toc}{chapter}{Acknowledgements}

The authors thank Christoph Kronenberg for comments and suggestions.

Development of this resource has received funding by
\href{https://www.dh.nrw/aktuelles/ausschreibung}{\emph{Data Literacy
Education.nrw}}. It is part of the
\href{https://www.uni-due.de/ub/datacampus/index.php}{DataCampus project
of the University of Duisburg-Essen}.

This concise guide to reproducible research using secondary data is
written as an Open Educational Resource to enable you to use this book
in the best possible way. This work is therefore made available under
Creative Commons Public Domain Dedication (CC0 1.0 Universal). You do
not have to ask us a permission to re-use and copy information from this
handbook. Take note that some materials cited in this book might be
copyright protected. If so, this is indicated in the text. Please
consider citing the handbook when using the content.

We have tried to acknowledge all of our sources. If for some reason we
have forgotten to provide you with proper credits it has not been done
with malicious intent. Feel free to contact us at
\href{mailto:katharina.blankart@uni-due.de}{\nolinkurl{katharina.blankart@uni-due.de}}
for any corrections.

\hypertarget{intro}{%
\chapter{Introduction to Reproducible Research}\label{intro}}

\begin{center}\includegraphics[width=1\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/anastasiia-kamil--uQZPtoJ8nk-unsplash} \end{center}

\emph{``Only results that can be replicated are truly scientific
results. If there is no chance to replicate research results, they can
be regarded as no more than personal views in the opinion or review
section of a daily newspaper.''} (Huschka
\protect\hyperlink{ref-huschka_why_2013}{2013})

\hypertarget{what-is-reproducible-research}{%
\section{What is reproducible
research?}\label{what-is-reproducible-research}}

Scientific journal editors and research funders are increasingly
promoting transparency in research. To encourage the principles of
reproducible research, the related institutions are requesting authors
to make their research reproducible. To overcome criticisms regarding
the validity and power of empirical tests, this means that data and
program code need to be shared upon manuscript acceptance, or at earlier
stages of the submission process. The purpose is that third-parties have
the possibility to reproduce the content, analysis, and conclusions of a
study on their own.

Efforts to increase reproducability have been expressed by institutions
within the social sciences including:

\begin{itemize}
\tightlist
\item
  The best practices statement by the
  \href{https://social-science-data-editors.github.io/template_README/}{Social
  Science Data Editors},
\item
  In Germany, by the German Research Foundation (DFG) and the Consortium
  for the Social, Behavioural, Educational and Economic Sciences
  \href{https://www.ratswd.de/en/publikationen/output}{RatWSD}
\item
  In editorial statement of journals, for example, American Economic
  Review, Management Science or the Journal of International Business
  Studies (Meyer, Witteloostuijn, and Beugelsdijk
  \protect\hyperlink{ref-meyer_whats_2017}{2017}; Orozco et al.
  \protect\hyperlink{ref-orozco_how_2020}{2020})
\end{itemize}

Generally, \textbf{\emph{reproducibility}} of research can be defined as
``the ability of a researcher to duplicate the results of a prior study
using the same materials and procedures as were used by the original
investigator. In an attempt to reproduce a published statistical
analysis, a second researcher might use the same raw data to build the
same analysis files and implement the same statistical analysis to
determine whether they yield the same results.'' (Bollen et al.
\protect\hyperlink{ref-bollen_social_2015}{2015}). Study results are
considered reproducible if after an article publication another
researcher can conduct the analyses using identical data and obtain the
same results using the material provided.

As empirical research is based on the application of a code to a dataset
to answer a pre-defined research question, ensuring the reproducibility
includes sharing the data and code to allow others to re-analyze the
data and to reproduce the reported results (Orozco et al.
\protect\hyperlink{ref-orozco_how_2020}{2020}). To achieve this, the
data and code need to be properly managed while working on a project.

Another concept closely related to \textbf{\emph{reproducibility}} is
the concept of \textbf{\emph{replicability}} that ``refers to the
ability of a researcher to duplicate the results of a prior study if the
same procedures are followed but new data are collected.'' (Bollen et
al. \protect\hyperlink{ref-bollen_social_2015}{2015}). Thus, for
example, if an investigator tries to replicate a scientific finding that
documents a relationship between two or more variables by using the same
scientific methodology but in a new setting, i.e.~with new data, and
fails to reach a similar conclusion, i.e.~replicate it -- a failure to
replicate occurs. The opposite is said to be true if the results are
replicated. Thus, \textbf{\emph{reproducibility}} and
\textbf{\emph{replicability}} are considered to be the two main elements
of empirical research.

To adapt reproducible practices early on, undergraduate and graduate
students are encouraged to perform reproducible research in their term
papers, theses, and practical applications as soon as possbile. For this
reason, university teachers are increasingly asking to submit
reproduction material (source data information, data programming and
analysis code) at all stages of a study.

The concept of reproducible research is not new and goes back as far as
the late 1800s (Vilhuber
\protect\hyperlink{ref-vilhuber_reproducibility_2020}{2020}). However,
reproducibility studies have disclosed that many rearchers do not follow
the principles of reproducible research. At the same time, the increase
in availability and use of public and especially non-public data
sources, and the increase in the reliance of research methods based on
specific software brings the principles of reproducible research on the
agenda of many researchers.

The resources boxes in each chapter provide material for best practices
in data and code management to perform a reproducible research project,
as well as in cleaning the data and conducting data analysis.

\hypertarget{why-you-as-a-student-and-researcher-should-care-about-reproducible-research}{%
\section{Why you, as a student and researcher, should care about
reproducible
research?}\label{why-you-as-a-student-and-researcher-should-care-about-reproducible-research}}

\hypertarget{avoid-common-biases-that-lead-to-biased-or-false-research-results}{%
\subsection{Avoid common biases that lead to biased or false research
results}\label{avoid-common-biases-that-lead-to-biased-or-false-research-results}}

\begin{figure}

{\centering \includegraphics[width=1\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/munafo} 

}

\caption{Threats to reproducible science}\label{fig:munafo}
\end{figure}

There is a number of threats to the reproducible research process that
can undermine scientific research or lead to false or biased conclusions
and publications. Figure @ref(fig:munafo) illustrates the main threats
to reproducible science (Munafò et al.
\protect\hyperlink{ref-munafo_manifesto_2017}{2017}).

\hypertarget{increase-productivity-of-your-work-and-the-work-of-the-scientific-community-by-performing-reproducible-research}{%
\subsection{Increase productivity of your work and the work of the
scientific community by performing reproducible
research}\label{increase-productivity-of-your-work-and-the-work-of-the-scientific-community-by-performing-reproducible-research}}

Following the reproducible research principles allows you to be a part
of a good academic practice that strives to improve the quality,
efficiency and reliability of scientific research.

\hypertarget{main-steps-to-generate-reproducible-research}{%
\section{Main steps to generate reproducible
research}\label{main-steps-to-generate-reproducible-research}}

To follow the best practices of reproducible research, you will need to
consider \textbf{\emph{how}} to perform your project and the
\textbf{\emph{steps a reproducible research project}} contains.

You may follow three main principles to enhance reproducible research
(Orozco et al. \protect\hyperlink{ref-orozco_how_2020}{2020}):

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\tightlist
\item
  \textbf{\emph{Organize your work:}} consider and plan your steps at
  the beginning of the project
\item
  \textbf{\emph{Code for others:}} set up each step of your project such
  that an outsider could follow your documentation
\item
  \textbf{\emph{Automate as much as you can:}} avoid processing analyses
  and results using point-and-click softare (MS Excel), export results
  directly and create a reproducible project documentation.
\end{enumerate}

\begin{figure}

{\centering \includegraphics[width=0.75\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/02_reproducible_research_data_analysis} 

}

\caption{Reproducible research}\label{fig:repro}
\end{figure}

In this study guide we follow the main steps of performing a
reproducible data science project (Bezjak et al.
\protect\hyperlink{ref-bezjak_open_2018}{2018}). To make your empirical
research study process reproducible, you need to follow these five steps
(Figure @ref(fig:repro)):

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\tightlist
\item
  \textbf{\emph{Formulating a hypothesis}} (Section @ref(hypothesis))
\item
  \textbf{\emph{Designing the study}} (Section @ref(designstudy))
\item
  \textbf{\emph{Running the study and collecting the data}} (Section
  @ref(run-study))
\item
  \textbf{\emph{Analyzing the data}} (Section @ref(analyzing))
\item
  \textbf{\emph{Reporting the study}} (Section @ref(report-study))
\end{enumerate}

\hypertarget{secondary-health-care-data}{%
\section{Secondary (health care)
data}\label{secondary-health-care-data}}

This study guide concentrates on empirical investigation using secondary
data, that means data that is not originally collected or generated by
the researcher for the purpose of the study. Secondary data covers any
existing data generated by companies, institutions, and individuals.

Examples of secondary data sources are routinelly collected health data
(administrative claims, electronic medical records), bibliometric data,
survey data, regulatory data, data generated in mobile applications.

\hypertarget{creating-an-environment-for-productive-research-projects}{%
\section{Creating an environment for productive research
projects}\label{creating-an-environment-for-productive-research-projects}}

\hypertarget{consider-using-agile-methods-to-organize-your-workflow-and-tasks}{%
\subsection{Consider using agile methods to organize your workflow and
tasks}\label{consider-using-agile-methods-to-organize-your-workflow-and-tasks}}

To set up your project, consider engaging project management tools. One
suitable method is working agile or based on SCRUM methods (Pirro
\protect\hyperlink{ref-pirro_how_2019}{2019},
@santiago--lopez\_six\_2019). Originating in software development,
working agile is highly suitable in performing research projects. A
planning protocol could include the following steps (as adapted from
(Pirro \protect\hyperlink{ref-pirro_how_2019}{2019})).

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\item
  \textbf{Split the work.} Slice a big chunk of work into several layers
  of activities, in which each layer is characterized by a tangible
  result to be obtained.Each layer is addressed in a dedicated, limited
  period of time (for example, 2--12 weeks), called a sprint.
\item
  Sprint planning. Meet your supervisor and any other stakeholders in a
  short meeting (around 30 minutes) with the aim of defining the goal of
  your sprint (for example, what you want to investigate) and its
  duration (1-4 weeks, for instance). Everybody has to agree on these
  two points, so that expectations are aligned and the whole research
  team is on the same page. On this occasion, the sprint-review meeting
  (see step five) can be scheduled.
\item
  \textbf{Sprint execution.} Work! Maximum focus is required on a
  specific task for a limited amount of time. You can do it, keep
  momentum.
\item
  Weekly scrum. Meet your supervisor for a maximum of 15 minutes, but
  ideally every week (for example, the same time slot every week and
  outside of conventional working hours to ensure there are no
  commitments, such as meetings or teaching activities, to get in the
  way). This meeting has to be short and efficient --- try to have a
  stand-up meeting with no laptops or papers. Only three questions need
  to be addressed: what was done the previous week to contribute to the
  goal? (For example, which data programs were developed? Which analyses
  were performed) What will be done next week to contribute to the goal?
  (For example, what analyses will be performed next?) And, are there
  any impediments? (For example, is the set-up working properly? Are all
  the materials and data needed available?)
\item
  \textbf{Sprint review, retrospective and planning.} At the end of the
  sprint, meet all of the stakeholders to discuss results and whether
  those are in line with expectations (review). Take some time to go
  into detail and do some analytical brainstorming together. Discuss the
  difficulties encountered, so that the next sprint is better than the
  previous one (retrospective). This is the phase for `impediment
  removal', or problem solving.
\end{enumerate}

Honesty and transparency are crucial. Agile is all about adapting to
change: plans can change. Go back to step one and restart the planning,
addressing the next layer of work in a new sprint.

You can execute the same routine even if you work idepenently.

\hypertarget{collaborate-with-others-and-get-feedback}{%
\subsection{Collaborate with others and get
feedback}\label{collaborate-with-others-and-get-feedback}}

\emph{Collaborate}: Before you start running the study you should assess
your available resources, that means time and own expertise to see
whether the study design is feasible. If there is an opportunity to work
collaboratively and you think that the project can benefit from the
expertise of another researcher, you can approach the person and ask
whether they would be interested to work together on the project.
Joining resources might relax your resource availability contraints. It
may further ensure that you engage in a reproducible research process.

\emph{Plan to get feedback - create your personal senior advisory
board}: Besides your collaborators, set up your personal senior advisory
board of the project. This could be anybody with experience related to
your research project (other students, PhD candiates). Define when you
plan to meet your advisors and present the progress of your work. Define
the specific competencies with which seniors can help you with your
project. This could include advising on study design, methods,
programming or interpretation of the results. If you work on a
longer-term project, find suitable workshops and conferences to present
your work and get feedback. Do not forget to account for time and
resources to proof-read and edit your research findings in a paper.

\hypertarget{resources-box}{%
\section{Resources Box}\label{resources-box}}

\begin{itemize}
\item
  An overview article of the principles of reproducible reserach and
  practical application: Orozco V, Bontemps C, Maigné E, Piguet V,
  Hofstetter A, Lacroix A, et al.~How to Make a Pie: Reproducible
  Research for Empirical Economics and Econometrics. Journal of Economic
  Surveys. 2020;34(5):1134--69. \url{https://doi.org/10.1111/joes.12389}
\item
  A guideline to minimize the risk of reporting false positives (type I
  errors), improve the quality of hypothesis-testing research and
  statistical reporting: Meyer, Klaus E., Arjen van Witteloostuijn, and
  Sjoerd Beugelsdijk. 2017. ``What's in a p? Reassessing Best Practices
  for Conducting and Reporting Hypothesis-Testing Research.'' Journal of
  International Business Studies 48 (5): 535--51.
  \url{https://doi.org/10.1057/s41267-017-0078-8}.
\item
  \href{https://blogs.worldbank.org/impactevaluations/curated-list-our-postings-technical-topics-your-one-stop-shop-methodology-0}{The
  Worldbank blog provides ``A Curated List of Our Postings on Technical
  Topics -- Your One-Stop Shop for Methodology''}
\end{itemize}

\hypertarget{checklist-to-get-started-with-your-reproducible-project}{%
\section{Checklist to get started with your reproducible
project}\label{checklist-to-get-started-with-your-reproducible-project}}

\begin{itemize}
\tightlist
\item
  Define the resources available and needed to perform your reproducible
  research project.
\item
  Set up a working plan that includes important milestones and minimal
  goals to achieve.
\item
  Decide for a project management method to organize your work, for
  example agile methods or SCRUM.
\item
  Define the tools and software for management of references, notes and
  editing of text and statistical software you will be using. Obtain
  access if needed.
\item
  Define relevant collaborators and stakeholders critical in persuing
  your reserach project.
\item
  Define important milestones and achievements.
\end{itemize}

\hypertarget{hypothesis}{%
\chapter{Formulating a hypothesis}\label{hypothesis}}

\begin{center}\includegraphics[width=1\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/idea4} \end{center}

\emph{``There is no single best way to develop a research idea.''}
(Pischke \protect\hyperlink{ref-pischke_how_2012}{2012})

\hypertarget{how-do-you-develop-a-research-question-and-formulate-a-hypothesis}{%
\section{How do you develop a research question and formulate a
hypothesis?}\label{how-do-you-develop-a-research-question-and-formulate-a-hypothesis}}

You decide to undertake a scientific project. Where do you start? First,
you need to find a research question that interests you and formulate a
hypothesis. We will introduce some key terminology, steps you can take,
and examples how to develop research questions. Note that .

\emph{What if someone assigns a topic to me? For students attending
undergraduate and graduate courses that often pick topics from a list,
all of these steps are equally important and necessary. You still need
to formulate a research question and a hypothesis. And it is important
to clarify the relevance of your topic for yourself.}

When thinking about a research question, you need to identify a topic
that is {[}based on {[}find source{]}{]}

\begin{itemize}
\tightlist
\item
  \emph{Relevant}, important in the world and interesting to you as a
  researcher: Does working on the topic excites you? You will spend many
  hours thinking about it and working on it. Therefore, it should be
  interesting and engaging enough for you to motivate your continued
  work on this topic.
\item
  \emph{Specific}: not too broad and not too narrow
\item
  \emph{Feasible} to research within a given timeframe: Is it possible
  to answer the research question based on your time budget, data and
  additional resources.
\end{itemize}

How do you find a topic or develop a feasible research idea in the first
place? Finding an idea is not difficult, the critical part is to find a
\textbf{good} idea. How do you do that? There is no one specific way how
one gets an idea, rather there is a myriad of ways how people come up
with potential ideas (for example as stated by (Varian
\protect\hyperlink{ref-varian_how_2016}{2016})).

You can find inspiration by

\begin{itemize}
\tightlist
\item
  Looking at insights from the world around you: your own life and
  experiences, observe the behavior of people around you
\item
  Talking to people around you, experts, other students, family members
\item
  Talking to individuals outside your field (non-economists)
\item
  Talking to professionals working in the area you are interested in
  (you may use social media and professional platforms like LinkedIN or
  Twitter to make contact)
\item
  Reading journal articles from other non-economic social sciences and
  the medical literature
\item
  Reading economic and non-economic newspapers and magazine articles
  (e.g., Süddeutsche, Frankfurter Allgemeine, Tagesspiegel, The
  Economist, the Wall Street Journal, The New York Times, The Guardian),
  watching TV programs

  \begin{itemize}
  \tightlist
  \item
    What are the issues being discussed?
  \item
    How do these issues affect people's lives?
  \end{itemize}
\end{itemize}

In addition you could

\begin{itemize}
\tightlist
\item
  Go to virtual and in-person seminars, for example, the
  \href{https://www.goek.wiwi.uni-due.de/forschung/essen-health-economics-seminar/winter-2020-21/}{Essen
  Health Economics Seminar}
\item
  Look at abstracts of scientific articles and working papers
\item
  Look at the literature in a specific field you are interested in, for
  example, screening complete issues of journals or editorials about
  certain research advancements. By reading this literature you might
  come up with the idea on how to extend and refine previous research.
\end{itemize}

Once you identified a research question that is of interest to you, you
need to define a hypothesis.

\hypertarget{what-is-a-hypothesis}{%
\section{What is a hypothesis?}\label{what-is-a-hypothesis}}

A hypothesis is a statement that introduces your research question and
suggests the results you might find. It is an educated guess. You start
by posing an economic question and formulate a hypothesis about this
question. Then you test it with your data and empirical analysis and
either accept or reject the hypothesis. It constitutes the main basis of
your scientific investigation and you should be careful when creating
it.

\hypertarget{develop-a-hypothesis}{%
\subsection{Develop a hypothesis}\label{develop-a-hypothesis}}

Before you formulate your hypothesis, read up on the topic of interest.
This should provide you with sufficient information to narrow down your
research question. Once you find your question you need to develop a
hypothesis, which contains a statement of your expectations regarding
your research question's results. You propose to prove your hypothesis
with your research by testing the relationship between two variables of
interest. Thus, a hypothesis should be testable with the data at hand.
There are two types of hypotheses: alternative or null. Null states that
there is no effect. Alternative states that there is an effect.

There is an alternative view on this that suggests one should not look
at the literature too early on in the idea-generating process to not be
influenced and shaped by someone else's ideas ((Varian
\protect\hyperlink{ref-varian_how_2016}{2016}).). According to this view
you can spend some time (i.e.~a few weeks) trying to develop your own
original idea. Even if you end up with an idea that has already been
pursued by someone else, this will still provide you with good practice
in developing publishable ideas. After you have developed an idea and
made sure that it was not yet investigated in the literature, you can
start conducting a systematic literature review. By doing this, you can
find some other interesting insights from the work of others that you
can synthesize in your own work to produce something novel and original.

\hypertarget{identify-relevant-literature}{%
\subsection{Identify relevant
literature}\label{identify-relevant-literature}}

For your research project you will need to identify and collect previous
relevant literature. It should involve a thorough search of the keywords
in relevant databases and journals. Place emphasis on articles from
high-ranking journals with significant numbers of citations. This will
give you an indication of the most influential and important work in the
field. Once you identify and collect the relevant literature for your
topic, you will need to \textbf{critically} synthesize it in your
literature review.

When you perform your literature review, consider theories that may
inform your research question. For example, when studying physician
behavior you may consider principal-agency theory.

\hypertarget{research-question-or-literature-review-the-chicken-or-the-egg-problem}{%
\subsection{Research question or literature review: the chicken or the
egg
problem?}\label{research-question-or-literature-review-the-chicken-or-the-egg-problem}}

Whether you start reading the literature first or by developing an idea
may depend on your level (graduate student, early career researcher) and
other goals. However, thinking freely about what you like to investigate
first may help to critically develop a feasible and interesting research
question.

We highlight an example how to start with investigating the real world
and subsequently posing a research question (``How to Write a Strong
Hypothesis Steps and Examples''
\protect\hyperlink{ref-noauthor_how_2019}{2019}; ``Developing Strong
Research Questions Criteria and Examples''
\protect\hyperlink{ref-noauthor_developing_2019}{2019}; Schilbach
\protect\hyperlink{ref-schilbach_5_2019}{2019}). For example, based on
your observation you notice that people spend extensive amount of time
looking at their smartphones. Maybe even you yourself engage in the same
behavior. In addition, you read a BBC News article
\href{https://www.bbc.com/news/technology-55826238}{Social media damages
teenagers' mental health, report says}.

\begin{figure}

{\centering \includegraphics[width=1\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/Social_media} 

}

\caption{Social media and mental health}\label{fig:social_media}
\end{figure}

Source: \href{https://www.bbc.com/news/technology-55826238}{BBC}

You decide to translate this article and your observations into a
\textbf{research question}: \emph{How does social media use affect
mental health?} Before you formulate your hypothesis, read up on the
topic of interest. Read economic, medical and other social science
literature on the topic. There is likely to be a vast amount of
literature from non-economic fields that are doing research on your
topic of interest, for example, psychology or neuroscience. Familiarize
yourself with it and master it. Do not get distracted by different
scientific methodologies and techniques that might seem not up-to-par to
the economic studies (small sample sizes, endogeneity, uncovering
association rather than causation, etc.), but rather focus on
suggestions of potential mechanisms.

A hypothesis is then your research question distilled into a one
sentence statement, which presents your expectations regarding the
results. You propose to prove your hypothesis by testing the
relationship between two variables of interest with the data at hand.
There are two types of hypotheses: alternative or null. The
\textbf{null} hypothesis states that there is no effect. The
\textbf{alternative} hypothesis states that there is an effect.

A hypothesis related to the above-stated research question could be:
\emph{The increased use of social media among teenagers leads to (is
associated with) worse mental health outcomes, i.e.~increased incidence
of depression, eating disorders, worse well-being and lower
self-esteem.} It suggests a direction of a relationship that you expect
to find that is guided by your observations and existing evidence. It is
testable with scientific research methods by using statistical analysis
of the relevant data.

Your hypothesis suggests a relationship between two variables: social
media use (your independent variable \(X\)) and mental health (dependent
variable \(Y\)). It could be framed in terms of correlation (is
associated with) or causation (leads to). This should be reflected in
the choice of scientific investigation you decide to undertake.

The \textbf{null} hypothesis is: \emph{There is no relationship between
social media use among teenagers and their mental health}.

\hypertarget{resources-box-1}{%
\section{Resources box}\label{resources-box-1}}

\hypertarget{how-to-develop-strong-research-questions}{%
\subsection{How to develop strong research
questions}\label{how-to-develop-strong-research-questions}}

\begin{itemize}
\tightlist
\item
  \href{https://www.economicsnetwork.ac.uk/handbook/ugresearch/31}{The
  form of the research process}
\item
  Varian, H. R. (2016).
  \href{https://journals.sagepub.com/doi/pdf/10.1177/0569434515627089}{How
  to build an economic model in your spare time.} The American
  Economist, 61(1), 81-90.
\end{itemize}

\hypertarget{identify-relevant-literature-from-major-general-interest-and-field-literature}{%
\subsection{Identify relevant literature from major general interest and
field
literature}\label{identify-relevant-literature-from-major-general-interest-and-field-literature}}

To identify the relevant literature you can

\begin{itemize}
\tightlist
\item
  use academic search engines such as Google Scholar, Web of Science,
  EconLit, PubMed. 
\item
  search working paper series such as the \href{www.nber.org}{National
  Bureau of Economic Research},
  \href{http://netec.wustl.edu/NetEc.html}{NetEc} or
  \href{www.iza.org}{IZA}
\item
  search more general resource sites such as
  \href{http://rfe.org}{Resources for Economists}
\item
  go to the library/use library database
\end{itemize}

\hypertarget{assess-the-quality-of-a-journal-article}{%
\subsection{Assess the quality of a journal
article}\label{assess-the-quality-of-a-journal-article}}

Several rankings may help to assess the quality of research you consider

\begin{itemize}
\tightlist
\item
  Journals of general interest and by field in economics and management
  - For German-speaking countries, consider the
  \href{https://www.forschungsmonitoring.org/}{VWL / BWL Handelsblatt
  Ranking} for economics and management - The German Association of
  Management Scholars provides an expert-based ranking
  \href{https://vhbonline.org/vhb4you/vhb-jourqual/vhb-jourqual-3/tabellen-zum-download}{VHB
  JourQual 3.0, Teilranking Management im Gesundheitswesen} - Web of
  Science Impact Factors - Scimago
\item
  Health Economics, Health Services and Health Care Managment Research:
  \href{https://www.mthooddiabeteschallenge.com/journal-list}{Health
  Economics Journals List}
\item
  Be aware that like in any other domain there are
  \href{https://predatoryjournals.com/}{predatory publishing practices}.
\end{itemize}

Use tools to investigate how a journal article is connected to other
works

\begin{itemize}
\tightlist
\item
  \href{https://citationgecko.azurewebsites.net/}{Citationgecko}
\item
  \href{https://www.connectedpapers.com}{Connected papers}
\item
  \href{https://scite.ai/}{scite\_} -- a tool to get a first impression
  whether a study is disputed or academic consensus
\end{itemize}

\hypertarget{organize-your-literature}{%
\subsection{Organize your literature}\label{organize-your-literature}}

\begin{itemize}
\tightlist
\item
  \href{https://www.zotero.org/}{Zotero} (free of charge)
\item
  \href{https://www.mendeley.com/guides/desktop}{Mendeley} (free of
  charge)
\item
  \href{https://endnote.com/}{EndNote} (potentially free of charge via
  your university)
\item
  \href{https://www.citavi.com/de}{Citavi} (potentially free of charge
  via your university)
\item
  BibTEX if you work with TEX
\item
  Excel spread sheet
\end{itemize}

\hypertarget{checklist-to-get-started-with-formulating-your-hypothesis}{%
\section{Checklist to get started with formulating your
hypothesis}\label{checklist-to-get-started-with-formulating-your-hypothesis}}

\begin{itemize}
\tightlist
\item
  Find an interesting and relevant research topic, if not assigned
\item
  Try to suck up all information you can easily obtain from various
  sources within and outside academic literature
\item
  Formulate one compelling research question
\item
  Find the best available empirical and theoretical evidence that is
  related to your research question
\item
  Formulate a hypothesis
\item
  Check whether data are available for analysis
\item
  Challenge your idea with your fellows or senior researchers
\end{itemize}

\hypertarget{example-hellerstein-1998}{%
\section{Example: Hellerstein (1998)}\label{example-hellerstein-1998}}

As an illustration of the research process of formulating a hypothesis,
designing a study, running a study, collecting and analyzing the data
and, finally, reporting the study, we provide an example by replicating
Judith K. Hellerstein's paper ``The Importance of the Physician in the
Generic versus Trade-Name Prescription Decision'' that was edited in
1998 in the The RAND Journal of Economics.

Hellerstein's 1998 paper has impacted discussion about behavioral
factors of physician decisions and pharmaceutical markets over two
decades. The study received 446 citations on
\href{https://scholar.google.de/scholar?cites=9301208853808127317\&as_sdt=2005\&sciodt=0,5\&hl=de}{Google
Scholar since 1998} by 22/02/2022, including recent mentions in top
field journals such as
\href{https://www.sciencedirect.com/science/article/abs/pii/S0047272718301968}{Journal
of Public Economics (2021)},
\href{https://www.sciencedirect.com/science/article/pii/S0167629617307348}{Journal
of Health Economics (2019)}, and
\href{https://onlinelibrary.wiley.com/doi/full/10.1002/hec.3774}{Health
Economics (2019)}.

\begin{figure}

{\centering \includegraphics[width=1\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/Hellerstein-connected-papers} 

}

\caption{Connected graph of Hellerstein (1998), February 2022}\label{fig:hellconnect}
\end{figure}

Figure @ref(fig:hellconnect) shows a connected graph of prior and
derivate works related to the study.

The work has impacted the literature researching the role of physician
behavior and its influence on access, adoption and diffusion of health
services, moral hazard and incentives in prescription and treatment
decisions and the influence of different payment schemes, and a vast
body of literature studying the pharmaceutical market.

The research that has been influenced by Hellerstein includes evidence
on:

\begin{itemize}
\tightlist
\item
  generic drug entries and market efficiency
\item
  the effectiveness of pharmaceutical promotion
\item
  the effectiveness of price regulations
\item
  the role of patents and dynamics of market segmentation
\end{itemize}

At the end of each chapter, we demonstrate insights into this study that
we replicated.

\hypertarget{context-of-the-study---escalating-health-expenditures}{%
\subsection{\texorpdfstring{\textbf{Context of the study - escalating
health
expenditures}}{Context of the study - escalating health expenditures}}\label{context-of-the-study---escalating-health-expenditures}}

In the United States, the total prescription drug expenditure in 2020
marked about 358.7 billion US Dollars (Statista
\protect\hyperlink{ref-statista_prescription_nodate}{n.d.}). The
prescription of generic drugs in comparison to more expensive brand name
versions is an option in reducing the total health care expenditure.
Generic drugs are bioequivalent in the active ingredients and can serve
as a channel to contain prescription expenditure (Kesselheim
\protect\hyperlink{ref-kesselheim_clinical_2008}{2008}) as generic drugs
are between 20 and 90\% cheaper than their trade-name alternatives
(Dunne et al. \protect\hyperlink{ref-dunne_review_2013}{2013}).

\hypertarget{research-question---how-does-a-patients-insurance-status-influence-the-physicians-choice-between-generic-compared-to-brand-name-drugs}{%
\subsection{\texorpdfstring{\textbf{Research question - How does a
patient's insurance status influence the physician's choice between
generic compared to brand-name
drugs?}}{Research question - How does a patient's insurance status influence the physician's choice between generic compared to brand-name drugs?}}\label{research-question---how-does-a-patients-insurance-status-influence-the-physicians-choice-between-generic-compared-to-brand-name-drugs}}

Physicians are faced with a multitude of medication options, including
the choice between generic and trade-name drugs. Physicians ideally act
as agents for their patients to identify the best available treatment
option based on their needs. Choosing the best treatment entails cost of
coordination and cognition. The prescription of generic drugs may serve
as an example to what extent physicians customize treatments according
to patients' needs with regards to cost. From an economic point of view
we may expect that once a generic drug is available, a perfectly
rational agent (i.e.~physician) would prescribe a generic drug instead
of the trade-name version if therapeutically identical (Dranove
\protect\hyperlink{ref-dranove_medicaid_1989}{1989}). This leads to the
following research question: \emph{``Do physicians vary their
prescription decisions on a patient-by-patient basis or do they
systematically prescribe the same version, trade-name or generic, to all
patients?''}.

The 1998 Hellerstein's study examines two hypotheses:

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\tightlist
\item
  The physician prescribing choice influences the selection of a generic
  over a brand-name drug
\item
  The patient's insurance status influences the physician's choice
  between generic and brand-name drugs.
\end{enumerate}

For the purpose of this example and in the replication exercise we focus
on the second aspect.

\hypertarget{hypothesis-1}{%
\subsection{\texorpdfstring{\textbf{Hypothesis}}{Hypothesis}}\label{hypothesis-1}}

The paper formulates the following hypothesis:

\textbf{Physicians are more likely to prescribe generics to patients who
do not have insurance coverage for prescription pharmaceuticals (moral
hazard in insurance)}

Hellerstein (1998) discusses that, based on insurance status, some
patients may demand certain care more than others. If, for example, the
prescription drug is reimbursed by the patient's health insurance, this
may cause overconsumption. This behavior can potentially differ by the
patient's insurance scheme. A patient that has no insurance and, thus,
does not get any reimbursement for prescription drugs, might have a
higher incentive to demand cheaper generic drugs (Danzon and Furukawa
\protect\hyperlink{ref-danzon_cross-national_2011}{2011}) than a patient
with insurance that covers prescription drugs, either generic or
trade-name. Given that the United States have different insurance
schemes with varying prescription drug coverage, it is of interest to
investigate the role of a patient's insurance status in the physician's
choice between generic compared to brand-name drugs.

Hellerstein (1998) considers a patient's insurance status as a matter of
dividing the study population in groups for which the choice between
generic and brand-name drugs differs. She suggests that \emph{There is a
relationship between the prescription of a generic drug and insurance
status of a patient.} (Hellerstein
\protect\hyperlink{ref-hellerstein_importance_1998}{1998}).

Providing answers to a research question requires formulating and
testing a hypothesis. Based on logic, theory or previous research, a
hypothesis proposes an expected relationship within the given data.
According to her research question, Hellerstein hypothesizes that:
\emph{Physicians are more likely to prescribe generics to patients who
do not have insurance coverage for prescription pharmaceuticals.}

Specifically, she writes \emph{``if there is moral hazard in insurance
when it comes to physician prescription behavior, there will be
differences in the propensity of physicians to prescribe low-cost
generic drugs, and these differences will be (partially) a function of
the insurance held by the patient. In particular, if moral hazard
exists, patients with extensive insurance coverage for prescription
drugs (like those on Medicaid in 1989) should receive prescriptions
written for generic drugs less frequently than patients with no
prescription drug coverage.''} (Hellerstein
\protect\hyperlink{ref-hellerstein_importance_1998}{1998}, 113)

Based on Hellerstein's considerations, we expect the effect of the
insurance status on whether a patient receives a generic to be different
from zero. To obtain a testable null hypothesis, we reformulate this
relationship so that we reject the hypothesis if our expectations are
correct. This means, if we expect to see an effect of insurance on
prescriptions of generics, our null hypothesis is that insurance status
has no effect on the outcome (prescription of generic drugs). No moral
hazard arises from having obtained insurance.

\hypertarget{designstudy}{%
\chapter{Designing the Study}\label{designstudy}}

\begin{center}\includegraphics[width=1\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/alice-dietrich-FwF_fKj5tBo-unsplash} \end{center}

\hypertarget{basic-steps-in-designing-your-study}{%
\section{Basic steps in designing your
study}\label{basic-steps-in-designing-your-study}}

You have chosen your research question and formulated a hypothesis. You
have collected and screened relevant literature on the topic. Now, you
need to decide on your research design. Are you planning to uncover
associations, or do you want to examine a causal relationship between
your variables of interest (Pearl
\protect\hyperlink{ref-pearl_causality_2009}{2009}; Pearl, Glymour, and
Jewell \protect\hyperlink{ref-pearl_causal_2016}{2016})? We will focus
on investigating causal relationships and analyzing counterfactual
situations. To translate direct observations in data to investigate
cause-and-effect relationships, you will need to rely on a workable
model that describes the elements and relationships of concepts
reflected in your hypothesis. It is strongly recommended that you first
describe the causal structures of the elements that you are studying,
including any other observed or unobserved structures that may disturb
the cause-and-effect relationship under investigation.

The three rungs of the ladder of causality can be shortly described as
\href{https://sobolevspace.com/causality/f/queries-of-causal-epistemology?blogcategory=Causality}{adapted
from Sobolev Spaces}

\begin{longtable}[]{@{}ll@{}}
\toprule
\begin{minipage}[b]{0.18\columnwidth}\raggedright
Rung\strut
\end{minipage} & \begin{minipage}[b]{0.76\columnwidth}\raggedright
Queries and targets\strut
\end{minipage}\tabularnewline
\midrule
\endhead
\begin{minipage}[t]{0.18\columnwidth}\raggedright
Level 1: ASSOCIATIONS\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Query: Is the outcome more common in one treatment group than the other?
Target: Difference between groups\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
Level 2: EFFECTS OF CAUSES\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Query: How would outcomes differ if treatment groups were made up of the
same subjects (individuals, neighborhoods, firms)? ; Target: Average
treatment effect\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
Level 3: CAUSAL ATTRIBUTION - COUNTERFACTUALS\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
CAUSATION\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Query: How likely is it that treatment is necessary and sufficient cause
of the outcome?; Target: Necessary and sufficient causes\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
MEDIATION\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Query: What part of the average treatment effect is not mediated by
other treatment outcomes?; Target: Natural direct effect\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
️PERSONALIZED EFFECT\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
How prevalent is responding differently to different treatments?;
Target: The probability of causation bounds\strut
\end{minipage}\tabularnewline
\bottomrule
\end{longtable}

Two approaches may be used to describe the causal relationships and the
estimable effects that you may identify as part of your research
question:

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\tightlist
\item
  Potential outcomes framework or PO-framework
\item
  Directed acyclic graphs
\end{enumerate}

Both approaches are the powerhouses to performing empirical analyses to
specify a) the effects that you aim to identify and b) the structural
relationships between the concepts (dependent variables, variables of
interests and confounders) under evaluation and c) whether your results
allow for causal inference given your data. Both approaches are powerful
and comprehensive. We keep this section short and refer to important
resources in this field below.

The design of your study will depend on the causal model that suggests
which effects are estimable, given that there are suitable data to
empirically identify the effect. Consider that you describe
cause-and-effect relationship first, assess how it is estimable (that
means that you ask the question ``Can you infer a causal effect from
your data?'') and then investigate the effect by direct observations
using secondary data.

\hypertarget{potential-outcomes-framework}{%
\subsection{Potential Outcomes
Framework}\label{potential-outcomes-framework}}

The potential outcomes framework uses the potential values of the
outcomes given a certain treatment (Abadie and Cattaneo
\protect\hyperlink{ref-abadie_econometric_2018}{2018}) to describe the
causal parameters that you aim to identify in your empirical analysis
and the type of effect. The PO-framework is particularly suited for
evaluating the effect of policies (governmental, firm policies). In
short, you would like to compare outcomes given a subject (individual,
firm, region) has received a treatment to the outcomes when the subject
has not received a treatment. The difference between the two will tell
you the treatment effect from having received the treatment or policy
under investigation by defining potential and realized outcomes. Using
the potential outcomes framework helps you to specify and assess whether
you can conclude that your estimands are coming from a population where
the treatment has been randomly assigned to subjects.

In the most simplest notation consider that there is a value of the
treatment by the (random) variable \(X\), or often denoted as \(W\) or
\(D\). We largely borrow from Abadie and Cattaneo
(\protect\hyperlink{ref-abadie_econometric_2018}{2018})'s annotation.
Consider that \(X\) has two values \(1\) that stands for that a subject
has received a treatment and \(0\) which stands for that the individual
has not received the treatment. The goal is to investigate the effect of
changes in \(X\) on some observed outcomes variable, denoted as \(Y\).
\(Y_1\) represents the potential value of the outcome when the value of
the treatment variable \(X\) is set to \(1\). \(Y_0\) represents the
potential value of the outcome when the subject does not receive the
treatment. The causal effect of the treatment can be represented by the
difference in potential outcomes, \(Y_1-Y_0\). The potential outcomes
and the value of the treatment define the observed outcome

\(Y=XY_1+(1-X)Y_0\)

Note that we typically cannot observe both potential outcomes in the
same subject which refers to as the fundamental problem of causal
inference. To be able to make causal statements, we need to make
additional assumptions to be able to estimate the average treatment
effect (ATE),i.e.

\(\tau_{ATE}=E[Y_1-Y_0]\)

This is a very short representation of the PO-Framework and we refer the
reader for the additional assumptions of identifiablity to the resources
box below.

\hypertarget{directed-acyclic-graphs}{%
\subsection{Directed Acyclic Graphs}\label{directed-acyclic-graphs}}

One way of describing your causal structure is by describing causal
relationship in directed acyclic graphs
\href{https://cran.r-project.org/web/packages/ggdag/vignettes/intro-to-dags.html}{(DAG)}.
A DAG is a systematic representation of a causal relationship between
two (or more) variables (\(X\) and \(Y\)) with a focus on minimizing
statistical bias by potential confounding variables (\(Z\)). It is
recommended to do this step before data collection. That way, you avoid
collection of data that may not be needed. You also avoid forgetting
variables that are necessary for causal effect identification. And you
may \href{https://ftp.cs.ucla.edu/pub/stat_ser/r493.pdf}{check for
so-called bad controls} that may bias your estimates.

\begin{figure}

{\centering \includegraphics[width=1\linewidth]{DataLiteracy_files/figure-latex/dagclassic-1} 

}

\caption{Directed Acyclic Graph}\label{fig:dagclassic}
\end{figure}

\hypertarget{develop-a-causal-model-and-identify-estimable-effects}{%
\subsection{Develop a causal model and identify estimable
effects}\label{develop-a-causal-model-and-identify-estimable-effects}}

We focus on study designs that use secondary data with the aim to
identify the magnitude of effects of causal relationships between a
variable of interest \(X\) and a certain outcome \(Y\), controlling for
potential confounders \(Z\). Note that there is extensive literature and
guidance about designing and performing causal inference studies, some
of which we guide you to below. We will highlight the most important
elements and point to the relevant resources.

Consider the subsequent steps as an iterative process, allowing that not
all data you may need to estimate effects of your causal model will be
readily available. Some elements will remain unobserved. For others, you
may need to find proxies.

You should specify a causal model that describes the relationships
between the elements that you are studying. This causal model will help
to identify an empirical model by defining your main relationship of
interest.

Generally speaking, you need to specify your

\begin{itemize}
\tightlist
\item
  main outcome variable of interest (\(Y\))
\item
  main independent variable of interest (\(X\))
\item
  other independent variables (confounders of the effect of \(X\) on
  \(Y\)), that means any additional \(Z\)'s
\item
  unobserved variable (\(U\))
\end{itemize}

You need to think about how these concepts can be measured and what the
relationships between these concepts are.

\hypertarget{develop-the-empirical-strategy-to-investigate-causal-effects}{%
\subsection{Develop the empirical strategy to investigate causal
effects}\label{develop-the-empirical-strategy-to-investigate-causal-effects}}

After you have specified your causal model, ask yourself how you can
capture the causal relationship between \(X\) and \(Y\)? In other words,
can you apply an appropriate research design that can accommodate you in
determining causality with the data at hand? Use the potential outcomes
framework notation to describe the types of effects you aim to identify.

Following the classification by Matthay et al.
(\protect\hyperlink{ref-matthay_alternative_2020}{2020}), that means
performing, for example, a

\begin{itemize}
\tightlist
\item
  Randomized Controlled Trial (RCT): this is be the ideal world case
  where we randomize treatments to study effects. You actively assign a
  treatment to subjects by chance.
\end{itemize}

Most secondary data are collected retrospectively and thus will not
allow performing a RCT as you will not be able to manipulate treatment
assignment. You will not be able to randomly assign subjects ahead of
time, such that you typically need to search for the best available
quasi-experiment to identify treatment effects using a

\begin{itemize}
\item
  Confounder Control Study

  \begin{itemize}
  \tightlist
  \item
    Regression adjustment
  \item
    Matching Techniques
  \item
    Simulation
  \item
    Random or Fixed effects regressions
  \item
    Instruments
  \item
    Regression discontinuity design (RDD)
  \item
    Difference-in-difference (DiD) analysis
  \item
    Instrumental variable (IV) approach
  \end{itemize}
\item
  Any other method such as synthetic control groups, structural equation
  models, causal machine learning
\end{itemize}

Think about what type of treatment effect you are investigating in your
causal analysis. The treatment effect is the average (across the
population or across some subpopulation) of the change in outcome
(\(Y\)) that results from a change in a covariate (the treatment \(X\))
(Lewbel \protect\hyperlink{ref-lewbel_identification_2019}{2019}).

Common types of treatment effect parameters are

\begin{itemize}
\tightlist
\item
  average treatment effects (ATE)
\item
  average treatment effects on the treated (ATT or ATET)
\item
  marginal treatment effects (MTE)
\item
  local average treatment effects (LATE)
\item
  quantile treatment effects (QTE)
\item
  intention to treat effect (ITT)
\end{itemize}

\hypertarget{investigate-suitable-source-data}{%
\subsection{Investigate suitable source
data}\label{investigate-suitable-source-data}}

You need to find and collect suitable data to populate your causal
model. This might take some time, and not all of the variables can be
found in one dataset. Frequently, different data sources need to be
collected and combined. You need to decide on what aggregation level you
need to conduct your analysis to estimate the cause-and-effect
relationships postulated, for example, individual (patient, student),
organization (hospital), regional (country, state). Given that, you need
to identify appropriate data sources that contain your variables of
interest at the given aggregation level.

When searching for the data sources, you can turn to already existing
datasets specifically designed for scientific use, for example, surveys
(\href{https://www.cdc.gov/nchs/ahcd/ahcd_questionnaires.htm}{NAMCS},
\href{https://www.census.gov/programs-surveys/cps.html}{CPS},
\href{https://www.nlsinfo.org/}{NLSY},
\href{https://melbourneinstitute.unimelb.edu.au/hilda}{HILDA},
\href{https://rlms-hse.cpc.unc.edu/}{RLMS},
\href{https://www.kiggs-studie.de/english/home.html}{KiGGS}); panels
(for example,
\href{https://www.eui.eu/Research/Library/ResearchGuides/Economics/Statistics/DataPortal/GSOEP}{GSOEP},
\href{http://www.share-project.org/home0.html}{SHARE},
\href{https://hrs.isr.umich.edu/data-products}{HRS},
\href{https://www.elsa-project.ac.uk/}{ELSA}); censuses (e.g.,
Microcensus).

Some data are available from statistical offices (Eurostat in the
European Union, DESTATIS for Germany), private companies (health
insurances), Social Media and App-based data (Mappiness, Fitbit,
Facebook, Twitter, WayBetter) or governmental and non-governmental
institutions (European Medicines Agency, Food and Drug Administration).
Sometimes you have to hand-collect and digitize the necessary data, for
example, from historical documents, data from governmental and
non-governmental agencies, commercial providers and library search
engines, archives; download statistical tables from INKAR's or
Unemployment Agency's websites. Therefore, you need to plan whether and
how these can be accessed and how much time is needed for extraction.
Consider automated tools like scraping.

\hypertarget{resources-box-2}{%
\section{Resources box}\label{resources-box-2}}

\hypertarget{key-terminology-in-causal-inference-based-on-matthay_alternative_2020}{%
\subsection{\texorpdfstring{Key terminology in causal inference based on
Matthay et al.
(\protect\hyperlink{ref-matthay_alternative_2020}{2020})}{Key terminology in causal inference based on Matthay et al. (2020)}}\label{key-terminology-in-causal-inference-based-on-matthay_alternative_2020}}

\begin{itemize}
\tightlist
\item
  \textbf{Causal model}: A description, most often expressed as a system
  of equations or a diagram, of a researcher's assumptions about
  hypothesized known causal relationships among variables relevant to a
  particular research question.
\item
  \textbf{Treatment, exposure, or independent variable}: The explanatory
  variable of interest in a study. Some also describe this as the
  ``right-hand-side variable''.
\item
  \textbf{Outcome, dependent variable, or left-hand-side variable}: The
  causal effect of interest in a research study is the impact of an
  exposure(s) on an outcome(s).
\item
  \textbf{Potential outcome}: The outcome that an individual (or other
  unit of analysis, such as family, neighbourhood, physician) would
  experience if his/her treatment takes any particular value. Each
  individual is conceptualized as having a potential outcome for each
  possible treatment value. Potential outcomes are sometimes referred to
  as counterfactual outcomes.
\item
  \textbf{Exogenous versus endogenous variables}: These terms are common
  in economics, where a variable is described as exogenous if its values
  are not determined by other variables in the causal model. The
  variable is called endogenous if it is influenced by other variables
  in the causal model. If a third variable influences both the exposure
  and outcome, this implies the exposure is endogenous.
\end{itemize}

\hypertarget{openly-available-textbooks-and-resources-on-econometrics-with-a-causal-inference-focus}{%
\subsection{Openly available textbooks and resources on econometrics
with a causal inference
focus}\label{openly-available-textbooks-and-resources-on-econometrics-with-a-causal-inference-focus}}

\begin{itemize}
\tightlist
\item
  \href{https://mixtape.scunning.com/}{Causal Inference: The Mixtape} by
  \href{http://www.scunning.com/}{Scott Cunningham}
\item
  \href{https://www.hsph.harvard.edu/miguel-hernan/causal-inference-book/}{What
  If} by Jamie Robin and Miguel Hernan
\item
  \href{http://nickchk.com/causalitybook.html}{The Effect: An
  Introduction to Research Design and Causality} by
  \href{http://nickchk.com/}{Nick Huntington-Klein}
\item
  \href{https://www.measureevaluation.org/resources/publications/ms-14-87-en.html}{How
  Do We Know if a Program Made a Difference? A Guide to Statistical
  Methods for Program Impact Evaluation} by MEASURE Evaluation
\item
  \href{https://ose-data-science.readthedocs.io/en/latest/lectures/index.html}{Open
  Source Economics Basics to microeconometric methods}
\item
  \href{https://www.econometrics-with-r.org/}{Introduction to
  Econometrics using R} by
  \href{https://www.oek.wiwi.uni-due.de/en/team/christoph-hanck/}{Christoph
  Hanck}
\item
  \href{https://www.ssc.wisc.edu/~bhansen/econometrics/}{Econometrics}
  by \href{https://www.ssc.wisc.edu/~bhansen/}{Bruce E. Hansen}
\item
  \href{https://mru.org/mastering-econometrics}{Mastering Econometrics}
  by \href{https://economics.mit.edu/faculty/angrist}{Joshua Angrist}
\item
  \href{https://diff.healthpolicydatascience.org/}{Differences-in-Difference
  design, Health Care Policy Science Lab}
\item
  \href{https://chabefer.github.io/STCI/}{Statistical Tools for Causal
  Inference} by the SKY Community
\end{itemize}

\hypertarget{ladders-of-causality-and-directed-acyclic-graphs}{%
\subsection{Ladders of causality and directed acyclic
graphs}\label{ladders-of-causality-and-directed-acyclic-graphs}}

\begin{itemize}
\tightlist
\item
  \href{https://theeffectbook.net/ch-CausalPaths.html}{A more
  comprehensive overview of causal paths is provided by Nick Huntington
  Klein}
\item
  A tool to draw Directed Acyclic Graphs (DAGs) is
  \href{http://www.dagitty.net/}{DAGitty}
\item
  \href{https://twitter.com/soboleffspaces/status/1491938765408931841?s=20\&t=RN_Ygh-E06bEt9uqf0Dgvw}{Pearl's
  Causal Epistemology}
\end{itemize}

\hypertarget{potential-outcomes-framework-notation}{%
\subsection{Potential outcomes framework
notation}\label{potential-outcomes-framework-notation}}

\begin{itemize}
\tightlist
\item
  \href{https://clas.ucdenver.edu/marcelo-perraillon/teaching/health-services-research-methods-i-hsmp-7607}{Causal
  Inference Chapter in Health Services Research Methods I}
\item
  \href{https://chabefer.github.io/STCI/FPCI.html}{The fundamental
  problem of causal inference}
\end{itemize}

\hypertarget{checklist-to-get-started-with-designing-your-study}{%
\section{Checklist to get started with designing your
study}\label{checklist-to-get-started-with-designing-your-study}}

\begin{itemize}
\tightlist
\item
  Describe your outcomes, variables of interest, confounders and
  potentially, unobserved variables
\item
  Identify at which rung in the ladder of causality you will be
  investigating your research question
\item
  Get familiar with the foundations of your selected identification and
  estimation strategy
\item
  Identify appropriate secondary data sources that populate your causal
  model, ensure that access is granted within the given time frame of
  your project
\item
  Challenge your identifiability assumtions
\item
  Refer back to similar empirical studies and reflect on their design
  and identification strategy
\end{itemize}

\hypertarget{example-hellerstein-1998-1}{%
\section{Example: Hellerstein (1998)}\label{example-hellerstein-1998-1}}

The identified research question and the hypothesis that physicians are
more likely to prescribe generics to patients who do not have insurance
coverage for prescription pharmaceuticals can be modelled with the help
of a directed acyclic graph (DAG).

\begin{Shaded}
\begin{Highlighting}[]
\CommentTok{#  set theme of all DAGs to `theme_dag()`--> minimalist }
\KeywordTok{library}\NormalTok{(ggdag)}
\KeywordTok{theme_set}\NormalTok{(}\KeywordTok{theme_dag}\NormalTok{())}

\NormalTok{Hellcoords <-}\StringTok{ }\KeywordTok{list}\NormalTok{(}
    \DataTypeTok{x =} \KeywordTok{c}\NormalTok{(}\DataTypeTok{Y =}\DecValTok{5}\NormalTok{, }\DataTypeTok{P=}\DecValTok{1}\NormalTok{, }\DataTypeTok{C=}\DecValTok{1}\NormalTok{, }\DataTypeTok{X=}\DecValTok{2}\NormalTok{, }\DataTypeTok{R=}\DecValTok{3}\NormalTok{,}\DataTypeTok{XP=}\DecValTok{4}\NormalTok{),}
    \DataTypeTok{y =} \KeywordTok{c}\NormalTok{(}\DataTypeTok{Y =}\DecValTok{0}\NormalTok{, }\DataTypeTok{P=}\DecValTok{0}\NormalTok{, }\DataTypeTok{C=}\OperatorTok{-}\DecValTok{1}\NormalTok{, }\DataTypeTok{X=}\OperatorTok{-}\DecValTok{1}\NormalTok{, }\DataTypeTok{R=}\OperatorTok{-}\DecValTok{1}\NormalTok{,}\DataTypeTok{XP=}\OperatorTok{-}\DecValTok{1}\NormalTok{))}


\NormalTok{Hellersteindag <-}\StringTok{ }\KeywordTok{dagify}\NormalTok{(Y }\OperatorTok{~}\StringTok{ }\NormalTok{P }\OperatorTok{+}\StringTok{ }\NormalTok{C }\OperatorTok{+}\StringTok{ }\NormalTok{X }\OperatorTok{+}\StringTok{ }\NormalTok{R }\OperatorTok{+}\StringTok{ }\NormalTok{XP,}
\NormalTok{                         P }\OperatorTok{~}\StringTok{ }\NormalTok{X }\OperatorTok{+}\StringTok{ }\NormalTok{XP }\OperatorTok{+}\StringTok{ }\NormalTok{C }\OperatorTok{+}\StringTok{ }\NormalTok{R,}
                         \DataTypeTok{labels =} \KeywordTok{c}\NormalTok{(}\StringTok{"Y"}\NormalTok{ =}\StringTok{ "Prescription of Generic Drug"}\NormalTok{,}
                                    \StringTok{"P"}\NormalTok{ =}\StringTok{ "Patient's Insurance Status"}\NormalTok{,}
                                    \StringTok{"C"}\NormalTok{ =}\StringTok{ "Drug Prices (Class Fixed Effects)"}\NormalTok{,}
                                    \StringTok{"X"}\NormalTok{ =}\StringTok{ "Patient Characteristics"}\NormalTok{,}
                                    \StringTok{"XP"}\NormalTok{ =}\StringTok{ "Practice Characteristics"}\NormalTok{,}
                                    \StringTok{"R"}\NormalTok{ =}\StringTok{ "Region"}\NormalTok{),}
                         \DataTypeTok{exposure =} \StringTok{"P"}\NormalTok{,}
                         \DataTypeTok{outcome =} \StringTok{"Y"}\NormalTok{, }\DataTypeTok{coords=}\NormalTok{Hellcoords)}

\CommentTok{#ggdag(Hellersteindag, text = TRUE, use_labels = "label")}

\KeywordTok{ggdag_classic}\NormalTok{(Hellersteindag)}
\end{Highlighting}
\end{Shaded}

\begin{figure}

{\centering \includegraphics[width=1\linewidth]{DataLiteracy_files/figure-latex/daghell-1} 

}

\caption{Directed Acyclic Graph, Hellerstein (1998)}\label{fig:daghell}
\end{figure}

Figure @ref(fig:daghell) points out the effect of interest as well as
potential confounders. Hellerstein sets up an observational,
retrospective analysis of secondary data, including patient and
physician characteristics. The goal of the analysis is to identify a
causal effect of the patient's insurance status (independent variable,
\(P\)) on the prescription of a generic over a trade-name drug
(dependent variable, \(Y\)). As the physician's prescription decision is
prone to involve information imperfections and agency problems, the
empirical model needs to control for physician-specific effects among
other possible influencing factors generally represented by confounders
\(Z\), and specifically by drug prices \(C\), patient characteristics
\(X\), practice characteristics \(XP\) and the region \(R\). Another
factor Hellerstein is concerned about is random variation at physician
level in the choice between generic and trade-name drugs.

The study is based on data from the
\href{https://ftp.cdc.gov/pub/Health_Statistics/NCHS/namcs_public_use_files/}{National
Ambulatory Medical Care Survey (NAMCS) 1991}, provided by Centers for
Disease Control and Prevention. The NAMCS is a national sample survey
administered by the National Center for Health Statistics. The NAMCS
data contain all actions taken by a physician in this period. NAMCS
allows controlling for physician-specific behavior that is necessary to
draw conclusions of our estimand, the effect of the patient's insurance
status.

The confounder control study design chosen by Hellerstein (1998) uses a
random effects probit specification at physician level to estimate the
effect of insurance status on generic compared to trade-name drug
choice. This includes the outcome variable (\(Y\)), a binary variable,
which indicates whether a patient has been prescribed a trade-name or a
generic drug. \(Y\) takes the value \(1\) if a generic drug or the value
\(0\) if a trade-name drug was prescribed. Of interest is the causal
effect of the patients' insurance types that include Medicare, Medicaid,
HMO/prepaid and private insurance. Other independent variables included
in the analysis for the purpose of reducing possible bias are the drug
class as proxy for prices, patient characteristics (age, gender, race),
physician specialist status, the region and the averages of patient
characteristics at physician level. The physician-level practice
demographics help portraying heterogeneity in the physician's practice
composition, as they contain all patients, including the patients that
did not receive any drug prescription.

Note that Hellerstein does not use the potential outcomes notation, but
we assume that the variables described as confounders besides the
variable of interest \(P\) represent all necessary confounding
variables. This assumption can only be informed from theory and cannot
be validated using empirical methods.

Hellerstein (1998) specifies the following estimation equation:

\[P(Generic_{ij}=1|C_k,X_i,\overline{P}_j,S_j, R_j,\overline{X}_j,\overline{P}_j)\]
\[= C_k\lambda+X_i\beta+C_kP_i\gamma+S_j\pi_1+R_j\pi_2+\overline{X}_j\pi_3+\overline{P}_j\pi_6+v_j+\epsilon_{ij}\]

where

\begin{itemize}
\tightlist
\item
  \(C_k\): drug classes
\item
  \(X_i\): vector of patient demographics
\item
  \(P_i\): insurance categories
\item
  \(S_j\): indicator if a physician is a specialist
\item
  \(R_j\): region
\item
  \(\overline{X}_j\): practice level patient characteristics based on
  \(X_i\)
\item
  \(\overline{P}_j\): share of patients in each insurance category in a
  physician's practice
\end{itemize}

Contrary to Hellerstein (1998), this equation leaves out indicators for
mandatory substitution laws, \(M\) and \(T\), as this information was in
confidential data files. Hellerstein describes that she uses a random
effects probit specification at physician level, however, the specified
equation looks different than the usual random effects specification.
You can find
\href{https://theeffectbook.net/ch-FixedEffects.html\#random-effects}{more
information on random effect models} in Huntington-Klein
(\protect\hyperlink{ref-huntington-klein_chapter_nodate}{n.d.}).

The choice of the covariates depends on the underlying causal model that
is rooted in theoretical considerations. Often you will not find all
variables that are confounders directly. Your creativity is needed to
find appropriate proxies in the data at hand to account for any relevant
possible biases. An example from Hellerstein's (1998) study design is
the need to include prices into the empirical analysis. Hellerstein
assumes that physicians are price sensitive. The physicians might not
know the true price difference between trade-name and generic drug, but
have an expectation of price differences. This poses a potential bias,
as the physician might alter her prescription style to these
expectations. Prices are not provided in NAMCS such that unobservable
price differences are accounted for by including drug class dummy
variables. The rationale for drug class dummies is that prices vary
across drug classes. Including drug class dummy variables allows
capturing variation in the prices of products indirectly.

The empirical specification by Hellerstein uses a random effects probit
estimator that is efficient under certain assumptions. The
identifiability of the effect of insurance status on generic compared to
brand-name products is not explicitly described. The specification of
the estimator is described in (Cameron and Trivedi
\protect\hyperlink{ref-cameron_microeconometrics_2005}{2005}, 705). Note
that while random effects estimators are typically used in panel data
that use a time dimension, Hellerstein uses multiple observations at
drug-class level instead of time dimensions.\footnote{A fixed effects
  estimator using physician-level fixed effects and additional
  specifications could considered more appropriate to capture the
  within-physician variation, we will not discuss alternative estimators
  contrary to Hellerstein's approach, but concentrate on the initial
  design.}

\hypertarget{run-study}{%
\chapter{Running the study and collecting the data}\label{run-study}}

\begin{center}\includegraphics[width=1\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/kaleidico-26MJGnCM0Wc-unsplash} \end{center}

In this chapter we specify how to collect and use the data. As this
study guide focuses on secondary data, you will need to identify
relevant data sources, obtain the source data and process them.

\hypertarget{basic-steps-when-collecting-the-data}{%
\section{Basic steps when collecting the
data}\label{basic-steps-when-collecting-the-data}}

As many data sources are not primarily developed for the particular
purpose of your study, you often will need to modify the source data to
reflect the measurements of your \(Y's\), \(X's\) and \(Z's\) you wish
to examine in your causal model. It is also often that secondary data is
not readily available for analysis such that you will need to collect
and process these data (for example, by writing a program that extracts
data from a website, search engine, or API, or by applying for
permission to access the data).

We distinguish between \textbf{source dataset(s)} and the
\textbf{analysis dataset} that you will be using to run the study.

We point to the following distinction that will have implications on the
resources needed to collect and process:

\begin{itemize}
\tightlist
\item
  Secondary source data that is readily available and has been
  documented earlier (for example, panels)
\item
  Secondary source data that you will need to process for the purpose of
  your study (for example, by use of web-scraping, use of web-APIs, or
  extraction from data warehouses)
\end{itemize}

The following steps are typically performed when collecting the data:

\hypertarget{identify-secondary-data-sources}{%
\subsection{Identify secondary data
sources}\label{identify-secondary-data-sources}}

Once you have designed the study, you can now search for appropriate
data sources of your \(X's\), \(Y's\) and \(Z's\). That means you
investigate which data items of one or multiple secondary data source(s)
you are using and how these items can be collected. You have to document
where, how and which data you gathered and processed. Specify exactly
the variables that you will be extracting and any exclusions of the data
source. If you are generating a dataset yourself from another source
through scraping techniques, you also need to document how the data are
collected and processed, for example, by sharing the corresponding
script and a description of that data.

You need to assess the suitability of the potential secondary data
sources. Types and use of secondary data sources have been described
across different disciplines, for example, Hair, Page, and Brunsveld
(\protect\hyperlink{ref-hair_nature_2019}{2019}) for business data,
Eriksson and Ibáñez
(\protect\hyperlink{ref-eriksson_secondary_2016}{2016}) for drug
utilization studies, Fitchett and Heafner
(\protect\hyperlink{ref-fitchett_quantitative_2017}{2017}) for social
studies. It is important to assess the quality of the secondary data
sources by the following criteria (Hair, Page, and Brunsveld
\protect\hyperlink{ref-hair_nature_2019}{2019}):

\begin{itemize}
\tightlist
\item
  \textbf{measurement validity}: This may be difficult to assess, but
  you may want to look for research that has used the data you aim to
  use
\item
  \textbf{reliability}: Does the source that you are using provide the
  data of sufficient quality?
\item
  \textbf{potential bias} This arises when the data do not measure what
  you want to measure. Biases may arise from, for example, changes in
  the sample from which the data are collected (for example, if an
  institution changes the way data are reported or if the sampled
  population is changing)
\end{itemize}

\hypertarget{develop-a-data-collection-and-analysis-plan}{%
\subsection{Develop a data collection and analysis
plan}\label{develop-a-data-collection-and-analysis-plan}}

\begin{itemize}
\tightlist
\item
  Use a data scheme to describe how you combine different secondary
  datasets into your analysis dataset.
\item
  Even if there is only one source dataset that you are using, you may
  need to think about how this dataset needs to be processed to be fit
  for your final analysis purpose.
\item
  Pay attention to how different data sources are linked: are there
  unique identifiers of the invidual subjects that you are studying (for
  example, identifiers for patients, physicians, firms, products). Are
  they the same across the different source data?
\item
  Per each dataset, describe which variables or items you plan to
  collect and how you aim to process the source data to fit the purpose
  of your study.
\end{itemize}

\hypertarget{obtain-access-to-source-data-or-generate-the-data}{%
\subsection{Obtain access to source data or generate the
data}\label{obtain-access-to-source-data-or-generate-the-data}}

\begin{itemize}
\tightlist
\item
  Investigate how you can obtain access to the data including
  permissions, fees and any ethical considerations.
\item
  Note that many data sources require registration and/or charge fees
  for obtaining access and processing requests. Special conditions for
  academics and students often apply. You may need to describe your
  research project and ask for permission. Allow these steps to take
  considerable time.
\end{itemize}

\hypertarget{basic-steps-when-processing-and-preparing-the-data}{%
\section{Basic steps when processing and preparing the
data}\label{basic-steps-when-processing-and-preparing-the-data}}

Once the \textbf{source data} has arrived, been extracted or simply you
hit the download button, you need to develop a program (Stata do-file,
R-code or code using other software) that documents the data extraction
steps and that leads to an analysis dataset. Make sure you save all raw
source data in a safe place that in terms of data protection it is
ensured, that you do not accidentally delete or overwrite these data.

When you develop the program, you will need to make decisions informed
by the previous steps related to

\begin{itemize}
\tightlist
\item
  Combining, merging, appending datasets
\item
  Specifying datasets and variables needed to estimate your regression
  model

  \begin{itemize}
  \tightlist
  \item
    Which variables are included/excluded?
  \item
    Which variables need to be modified (recoded/calculated)? How?
  \item
    Creating new variables
  \item
    Labeling the variables
  \end{itemize}
\item
  Defining the study period
\item
  Defining exclusion criteria (for example, teens or adults only,
  general practicioners or physicians)
\item
  Aggregating to the appropriate level (individual, family, county,
  state, country, patient, physician, or hospital, etc.)
\item
  Specifying the final analysis dataset: what outcomes (\(Y\)),
  variables of interest (\(X\)), confounders (other \(X\)'s),
  instruments (\(Z\)) are possible to use from the data?
\end{itemize}

\hypertarget{generate-the-analysis-dataset}{%
\subsection{Generate the analysis
dataset}\label{generate-the-analysis-dataset}}

There are three major tasks that are typically needed to generate the
analysis dataset:

\textbf{1. Clean your data.}

\begin{itemize}
\tightlist
\item
  get/collect the data and transfer them in a format you use, for
  example, to .dta from .xlsx (if neccessary)
\item
  Make sure that you link different datasets correctly using correct
  identifiers.
\item
  Take time to look through the data, check them, and delete anything
  that looks suspicious.
\item
  Select your sample of interest.
\item
  Generate and leave only variables necessary for your anaylsis.
\item
  Ensure that you make plausible and relevant exclusion decisions, for
  example, regarding the time period studied, products, health
  conditions, age groups.
\end{itemize}

\textbf{2. Structuring and aggregating of the analysis data}

\begin{itemize}
\tightlist
\item
  Only include variables of your empirical model in the analysis
  dataset!
\item
  Aggregate your data to the level of analysis. For example, if you aim
  to analyze physician behavior over time, there should be one
  observation for each time period and physician (panel data). If your
  data are purely cross-sectional, there should not be multiple time
  periods in your data. That means in a cross-section of physicians, one
  row represents one physician.
\end{itemize}

\textbf{4. Store your data}

\begin{itemize}
\tightlist
\item
  Your analysis dataset is the most important piece for your analysis.
\item
  Physically store the version of your analysis dataset that you are
  using.
\item
  Use version control if you are modifying your analysis dataset.
\item
  Ensure that the code to create your analysis dataset is complete and
  can reproduce the analysis dataset completely.
\end{itemize}

\hypertarget{resources-box-3}{%
\section{Resources Box}\label{resources-box-3}}

\hypertarget{how-to-organize-your-research-project}{%
\subsection{How to organize your research
project:}\label{how-to-organize-your-research-project}}

\begin{itemize}
\tightlist
\item
  \href{https://towardsdatascience.com/how-to-keep-your-research-projects-organized-part-1-folder-structure-10bd56034d3a}{Folder
  structure}
\item
  \href{https://research.cs.queensu.ca/home/audrey/papers/GHC2009.BOFslides.pdf}{Tips,
  tricks and software for keeping research organized}
\item
  \href{https://twp.duke.edu/sites/twp.duke.edu/files/file-attachments/research_project.pdf}{Organizing
  a research project}
\end{itemize}

\hypertarget{coding-practices-best-practices-for-data-and-code-management-in-projects}{%
\subsection{Coding practices: Best Practices for Data and Code
Management in
Projects}\label{coding-practices-best-practices-for-data-and-code-management-in-projects}}

General principles on \textbf{How to code well}

\begin{itemize}
\tightlist
\item
  Make program files self-contained
\item
  Use relative paths
\item
  Identify inputs and outputs
\item
  Automize
\item
  Be consistent
\item
  Comment and document
\item
  Use spacing and indentation
\item
  Do not substitue brevity for readability
\item
  Beware of error causing codes (small caps, commas, semicolon)
\end{itemize}

\hypertarget{data-cleaning}{%
\subsection{Data cleaning}\label{data-cleaning}}

\begin{itemize}
\tightlist
\item
  \href{https://mdl.library.utoronto.ca/technology/tutorials/cleaning-data-stata}{Cleaning
  data in STATA}
\end{itemize}

\hypertarget{collecting-data-from-meta-data-and-web-scraping}{%
\subsection{Collecting data from meta-data and
web-scraping}\label{collecting-data-from-meta-data-and-web-scraping}}

\begin{itemize}
\tightlist
\item
  \href{https://librarycarpentry.org/lc-webscraping/reference}{Introduction
  to web scraping: Resources}
\end{itemize}

\hypertarget{checklist-to-running-the-study-and-collecting-the-data}{%
\section{Checklist to running the study and collecting the
data}\label{checklist-to-running-the-study-and-collecting-the-data}}

\begin{itemize}
\tightlist
\item
  Develop a data extraction and analysis plan by describing how your
  final analysis data set should look like
\item
  Set up data extraction methods if your data is not readily available
  to use, for example a scraping algorithm
\item
  Go back to your causal model and identification strategy: Does the
  analysis data allow the analysis you like to perform? Most
  importantly, is it collased at the level needed?
\item
  Set up a reproducible program code of all steps that you take to
  clean, combine and aggregate the data
\item
  Store and document your analysis data set in a codebook
\end{itemize}

\hypertarget{example-hellerstein-1998-2}{%
\section{Example: Hellerstein (1998)}\label{example-hellerstein-1998-2}}

The empirical application of Hellerstein (1998) is based on three
datasets as provided by the National Ambulatory Care Survey (NAMCS) from
the year 1989:

\begin{itemize}
\tightlist
\item
  \textbf{NAMCS}, containing demographic and medical information on the
  full sample of patients
\item
  \textbf{NAMCSd}, containing information on medications prescribed or
  given to a subsample of patients of the NAMCS data.
\item
  \textbf{NAMCS confidential data}, key to identifying physicians state
  of origin
\end{itemize}

The confidential data are not publicly available but are key to
identifying physicians and patients. Thus, for the purpose of
reproducing Hellerstein's results, we resort to the publicly available
data of 1991, that provide these identifiers in two publicly available
datasets:

\begin{itemize}
\tightlist
\item
  \textbf{NAMCS}, containing demographic and medical information on the
  full sample of patients (documentation can be found
  \href{https://www.cdc.gov/nchs/ahcd/datasets_documentation_related.htm}{here}).
\item
  \textbf{NAMCSd}, containing information on medications prescribed or
  given to a subsample of patients of the NAMCS data (documentation can
  be found
  \href{https://www.cdc.gov/nchs/ahcd/datasets_documentation_related.htm}{here}).
\end{itemize}

The NAMCS contains data on patient visits to non-federally employed
physicians in the United States. For each visit, the physician or other
staff members have to complete a one-page survey form containing inter
alia patient demographics including the patient's insurance status,
diagnoses, types of health behavior counselling, medications ordered or
provided, as well as provider characteristics. As the physicians are
randomly chosen and randomly assigned to a two-week reporting period,
the NAMCS is able to create a nationally representative sample.

The publicly available data of NAMCS and NAMCSd come in an .exe format
and can be downloaded at the
\href{https://www.cdc.gov/nchs/ahcd/datasets_documentation_related.htm}{Centers
for Disease Control and Prevention (CDC) website}. We use the unpacking
software 7-zip to convert the files in a .txt format. The NAMCS dataset
contains demographic and medical information on the full sample of
patients and is mainly used to introduce the sample. The NAMCSd is a
subsample of patients of the NAMCS data. It is the sample used for all
estimations later on. In it, each observation covers one medication,
that was mentioned, prescribed or given to a patient, and comes along
with further information on both the medication and the patient
receiving it.

Usually, certain transformations need to be performed to be able to use
the raw dataset. This can apply to the file or data format, the
structure of the dataset or you might need to combine different
datasets.

After downloading the raw data from the CDC website, a challenge is to
structure the raw dataset to be able to use the relevant variables in
Stata. After importing the text file, all data were condensed to one
string of characters in a single column. This means that we first need
to indicate the different data items (variables) for the individual
information (i.e.~patient characteristics). Therefore, to be able to use
the data, we need to manually split the string into the desired format,
so the information is split in separate variables. Which digits in the
initial string belong to one data item is defined in the documentation
files (also often referred to as a codebook) provided by the
\href{https://www.cdc.gov/nchs/ahcd}{CDC} website. Almost every dataset
comes with a codebook, containing useful information on the coding or
handling of the data. This can often help and provide the necessary
information needed to successfully prepare your data for empirical
analysis.

For the reproduction of Hellerstein (1998) we use Stata, creating a
do-file containing the code (Section @ref(A1)). It is important to
develop a program file of your code containing every step you performed
to manipulate and analyze your data. This ensures the reproducibility of
your research and enables you to go back to earlier versions of your
data preparation and analysis, if necessary.

Before going into further detail on the data preparation, we want to
emphasize on the importance of properly setting up your working
directory. In a single project you are likely to save, use, override and
delete a multitude of files. Without using a strict system of organizing
your files and folders, you will inevitably run into trouble. There is
no optimal structure, and you must find what works best for you, but in
general, contents of folders and subfolders should be as homogenous as
possible. To make this less abstract, let us demonstrate how we manage
our working directory on the data-related part of this reproduction
paper.

The Stata code is the heart of your empirical analysis. To make it as
comprehensible as possible, we divided the code into four parts. The
first part translates the raw data into a readable format, the second
one applies Hellerstein's preparatory processes, the third reproduces
the descriptive statistics and the last contains the code to run the
empirical analysis. Corresponding to these do-files, we created
sub-folders that contain required data or offer a place to store the
output. By saving the paths to all your relevant subfolders as global,
you can easily navigate through your working directory. Setting up your
working directory at the start of a project will also help you to keep
an overview on what is done and what is to come. You can find an example
of the pathing and setup in (Section @ref(A1) line 12 to 21).

Once the NAMCS and NAMCSd are turned into readable formats we perform
the following cleaning (i.e.~exclusion of certain observations),
transforming and preparation steps, that are needed to reproduce the
tables and figures originally produced by Hellerstein (1998):

For the NAMCS, used exclusively for the reproduction of table 1 (Section
@ref(A1)):

\begin{itemize}
\tightlist
\item
  Missing data must be relabelled according to the syntax of the
  statistical software and observations with missing data were not
  considered.
\item
  Keep only those observations that uniquely identify a single source of
  payment, meaning to drop observations with (A) missing insurance
  status, or (B) multiple insurance statuses. Step (B) is not mentioned
  in the text but can be inferred by the values of Table 1. Despite some
  observations reporting multiple sources of payment, the means of the
  mentioned payment/insurance options aggregate to 1. Thus, Hellerstein
  must have treated these observations as invalid.
\item
  The setup of the dummy variables for Medicare and Specialists underlie
  special conditions (details can be found in the do-file attached),
  whereas the remaining dummies were not created straight away.
\end{itemize}

For the NAMCSd, used for all other figures and tables,

\begin{itemize}
\tightlist
\item
  Clear missing values and perform steps (A) and (B) as in the NAMCS
  data.
\item
  Although reported in the table 1, drop observations that report `other
  government insurance' as a source of payment.
\item
  Keep only those observations of drugs that are the first mentioned
  drug in a patient visit.
\item
  Keep only those observations of drug mentions, that are part of the
  eight largest drug classes. The names of the included drug classes can
  be found in table 3 and the labels the data use in the documentation
  files.
\item
  Keep only those observations of drugs that were prescribed.
\item
  Create the same dummies as in the preparation of the NAMCS data
  (footnote table 2, @ref(tab:HellTab2))
\item
  Create an indicator on whether a drug is a multisource drug
  (definition given in ch.1 paragr. 1: ``We categorized drugs with the
  same ingredients and define drugs in an ingredient-group as
  multisource if there is at least one generic and one tradename drug
  within a group.'').
\item
  Drop observations of medications that are not multisource drugs.
\item
  Use the variable on whether a drug is a generic or trade-name drug to
  create an indicator on whether the drug is a generic (dependent
  variable).
\item
  Create physician averages of variables listed on p.~123 in Hellerstein
  (1998).
\end{itemize}

After completion of these steps, the analysis dataset NAMCS includes 43
variables and 33,123 observations and NAMCSd 29 variables and 8,397
observations. The dataset is aggregated on patient level and is now
ready for statistical analysis (see at the end of the next chapter). Of
importance is to ensure that the raw data, the data preparation do-file
and the analysis dataset are stored safely.\\
The NAMCSd dataset serves as a source for the empirical analysis of
Hellerstein (1998).

\textbf{Table (\#tab:analysisdat): Variables of the analysis dataset
based on NAMCSd}

\begin{longtable}[]{@{}ll@{}}
\toprule
\begin{minipage}[b]{0.18\columnwidth}\raggedright
Variable Name\strut
\end{minipage} & \begin{minipage}[b]{0.76\columnwidth}\raggedright
Label\strut
\end{minipage}\tabularnewline
\midrule
\endhead
\begin{minipage}[t]{0.18\columnwidth}\raggedright
generic\_status\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
1 if patient receives generic drug, 0 if trade-name\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
ingredients\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Ingredients of the drug prescribed\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
drug\_class\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
8 largest drug classes prescribed\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
age\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Patient age\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
hmo\_pre\_paid\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
HMO insurance\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
medicare\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Medicare insurance\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
medicaid\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Medicaid insurance\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
other\_gov\_ins\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Other government insurance\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
private\_ins\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Private insurance\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
selfpay\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
No insurance\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
other\_pay\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Other payment\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
physician\_id\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Physican individual indicator\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
patient\_id\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Patient individual indicator\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
female\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
1 if patient is female, 0 if male\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
nonwhite\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
1 if patient is nonwhite, 0 if otherwise\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
hispanic\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
1 if patient is hispanic, 0 if otherwise\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
northeast\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
1 if practice setting is in the northeast, 0 if otherwise\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
midwest\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
1 if practice setting is in the midwest, 0 if otherwise\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
south\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
1 if practice setting is in the south, 0 if otherwise\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
west\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
1 if practice setting is in the west, 0 if otherwise\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
specialist\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
1 if physician is a specialist, 0 if otherwise\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
mean\_age\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Mean age of patients in an individual practice\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
mean\_female\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Mean percentage of females in an individual practice\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
mean\_nonwhite\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Mean percentage of nonwhites in an individual practice\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
mean\_hispanic\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Mean percentage of hispanics in an individual practice\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
mean\_medicare\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Mean percentage of patients with medicare insurance in an individual
practice\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
mean\_medicaid\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Mean percentage of patients with medicaid insurance in an individual
practice\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
mean\_hmo\_pre\_paid\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Mean percentage of patients with HMO insurance in an individual
practice\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.18\columnwidth}\raggedright
mean\_private\_ins\strut
\end{minipage} & \begin{minipage}[t]{0.76\columnwidth}\raggedright
Mean percentage of patients with private insurance in an individual
practice\strut
\end{minipage}\tabularnewline
\bottomrule
\end{longtable}

Table @ref(tab:analysisdat) shows the variables included in the dataset.

\hypertarget{analyzing}{%
\chapter{Analyzing the Data}\label{analyzing}}

\begin{center}\includegraphics[width=1\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/mike-u-SGcFBTuSSU4-unsplash} \end{center}

\hypertarget{basic-steps-when-analyzing-the-data}{%
\section{Basic steps when analyzing the
data}\label{basic-steps-when-analyzing-the-data}}

Think again about your research question and what you are trying to
learn or discover. How can you use your data to answer this question?

The data to be analyzed should correspond to the core elements of the
hypothesis to be investigated. You investigate whether the postulated
cause-effect relationship exists, or quantitatively identify the
strength of the effect. To perform a reproducible research project, you
need to generate an \textbf{analysis dataset}. For information on how to
generate an analysis dataset and how to create a set of programs that
describes how the secondary data used were synthesized, processed and
analyzed, go to
\protect\hyperlink{ux5cux23-Basic-steps-when-processing-and-preparing-the-data}{Basic
steps when processing and preparing the data}.

Using your \textbf{analysis dataset} you perfrom two more steps to
examine your research question. Across both steps, try to use data
visualization with tables and graphs. They are an essential part of your
work and not an accessory. Visualizations help to support the
argumentation in the text and visualize complex facts in a simple form.

In the following, we describe the two major tasks for data analysis

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\tightlist
\item
  Describe your data, assess validity and plausiblity
\item
  Generate estimates of your investigated effect using regression
  techniques
\end{enumerate}

\hypertarget{describe-your-data-assess-validity-and-plausiblity}{%
\subsection{Describe your data, assess validity and
plausiblity}\label{describe-your-data-assess-validity-and-plausiblity}}

Start the data analysis by doing some descriptive analyses of your data
and sample. Once you have selected the necessary variables, generated
new variables for the analysis, and combined all the necessary datasets
into one analysis dataset you can start your empirical investigation.

\begin{itemize}
\tightlist
\item
  Check the plausibility by looking at basic descriptives (N, mean,
  median, frequencies)
\item
  Plot the distribution of your data using histograms, boxplots, bar
  charts
\item
  Critically reflect any anormalities: Compare your data with the
  reference literature
\item
  Are descriptives similar? If not, why so? Try to assess coding
  problems, different population, unbalanced samples.
\end{itemize}

\hypertarget{generate-estimates-of-your-investigated-effect-using-regression-techniques}{%
\subsection{Generate estimates of your investigated effect using
regression
techniques}\label{generate-estimates-of-your-investigated-effect-using-regression-techniques}}

\begin{itemize}
\item
  Once you have decided on the type of empirical analyses you would like
  to perform, run the regressions.
\item
  Perform the regression analyses. That means use the appropriate
  procedure to estimate regressions that reflect your empirical
  strategy.
\item
  Create output tables that report your results which outsiders can
  understand. Label your variables properly
\item
  Concentrate on analyzing and interpreting the effects of your variable
  of interest (\(X\))

  \begin{itemize}
  \tightlist
  \item
    interpret and show in tables only most important and relevant
    coefficients related to the research question. For example, you do
    not need to interpret and display coefficients for all of the
    incuded control variables, just the main variables of interest.
  \end{itemize}
\item
  Think about how to interpret your estimates.
\item
  Challenge your approach. Investigate why your estimates could not be
  plausible?
\item
  Again, compare with existing literature.
\item
  What do your data say? After you run the regressions, look at the
  results:

  \begin{itemize}
  \tightlist
  \item
    Are your main coefficients of interest statistically significant: is
    the p-value smaller than 0.05 or any other pre-defined level of
    significance?
  \item
    Consider also the economic significance of your results. Is the
    effect you are measuring large or small?
  \item
    Do your results make sense or are they counterintuitive? This might
    give you a clue that you might have misspecified your regression or
    made a mistake in your analysis.
  \end{itemize}
\end{itemize}

\hypertarget{resources-box-4}{%
\section{Resources box}\label{resources-box-4}}

\textbf{Repsitories of statistical techniques, including data wrangling}

\begin{itemize}
\tightlist
\item
  LOST - Library of Statistical Techniques
  (\url{https://lost-stats.github.io/})
\end{itemize}

\textbf{Data Analysis}

\begin{itemize}
\tightlist
\item
  \href{https://dss.princeton.edu/training/}{Princeton University
  Library: Getting Started in Data Analysis using Stata and R}
\item
  \href{https://gabors-data-analysis.com/}{Data Analysis for Business,
  Economics, and Policy}
\end{itemize}

\textbf{Organizing your workflow, programming and automation}

\begin{itemize}
\tightlist
\item
  \href{https://web.stanford.edu/~gentzkow/research/CodeAndData.pdf}{Gentzkow
  M, Shapiro J. Code and Data for the Social Sciences: A Practitioner's
  Guide {[}Internet{]}. Chicago Booth and NBER; 2014}
\item
  \href{https://medium.com/the-stata-guide/the-stata-workflow-guide-52418ce35006}{The
  Stata workflow Guide}
\item
  \href{https://michaelshill.net/2015/07/31/in-stata-coding-style-is-the-essential/}{In
  Stata coding, Style is the Essential: A brief commentary on do-file
  style}
\end{itemize}

\textbf{Data Visualization}

\begin{itemize}
\tightlist
\item
  The chapter
  \href{https://hhsievertsen.github.io/EconDataBook/data-visualization-basics.html}{Data
  Visualization Basics by Hans Sievertsen} includes important resources
  for the fundamentals of data visualization
\item
  \href{https://www.stata.com/bookstore/stata-cheat-sheets/}{Stata Cheat
  Sheet on Visualization} provides an overview of the technical
  implementation
\item
  \href{https://doi.org/10.1561/0800000033}{Jones AM. Data visualization
  and health econometrics. Foundations and Trends in Econometrics. 2017}
\end{itemize}

\textbf{Create journal submission-ready output tables}

\begin{itemize}
\tightlist
\item
  \href{https://ssc.wisc.edu/sscc/pubs/stata_tables.htm}{Creating
  Publication-Quality Tables in Stata}
\item
  \href{http://repec.sowi.unibe.ch/stata/}{Stata commands to plot
  regression coefficients, make regression tables and visualize results
  by Ben Jann}
\end{itemize}

\hypertarget{checklist-to-analyzing-the-data}{%
\section{Checklist to analyzing the
data}\label{checklist-to-analyzing-the-data}}

\begin{itemize}
\tightlist
\item
  Follow your research question and hypothesis. Do not alter it while
  analyzing the data.
\item
  Do your results make sense? If not, rule out any programming errors?
\item
  Try to interpret your data? How big is your effect? Is it small or
  large?
\item
  Use visualizatoin techniques as often as possible to analyse your
  data.
\item
  Discuss your results with
\end{itemize}

\hypertarget{example-hellerstein-1998-3}{%
\section{Example: Hellerstein (1998)}\label{example-hellerstein-1998-3}}

Hellerstein's 1998 study aims to identify the role the physician plays
in prescribing a generic over a trade-name drug and the role of a
patient's insurance status. To identify this, we analyze the secondary
data on physician level in cross-sectional format (NAMCS and NAMCSd,
described in the chapter ``running the study and collecting the data'').
The primary interest is to investigate if physicians do or do not
prescribe a generic drug and whether this is influenced by the patient's
insurance status. We are not investigating prescription behavior of
physicians over time using panel data.

Over the course of the analysis, we want to explore the dataset. This
includes describing and assessing the validity and plausibility. Thus,
before generating estimates of the effect of interest using regression
techniques, we describe the data using descriptive statistics presented
in tables and figures.

We first reproduce the descriptive statistics of Hellerstein (1998),
namely tables 1-3 and figures 1-2. Details on created variables can be
found in the data preparation do-file (Sections @ref(A1)-@ref(A3)) and
the notes to the tables and figures in Hellerstein's 1998 paper. The
code for the reproduction of the descriptive statistics (i.e.~the
reproduction of tables and figures), can be found in (Section @ref(A2).
Please keep in mind that we use the data from 1991. Thus, our numbers
are not matching with the numbers provided in the original paper.

\hypertarget{describe-your-data-assess-validity-and-plausiblity-1}{%
\subsection{Describe your data, assess validity and
plausiblity}\label{describe-your-data-assess-validity-and-plausiblity-1}}

\hypertarget{table-1}{%
\subsubsection{Table 1}\label{table-1}}

We compute the mean and summary statistics for the age and the
previously established dummies in the NAMCS data (Section @ref(A2) lines
144-165).

\textbf{Hellerstein Table 1 - Summary Statistics for Overall NAMCS
Patient Sample}

\begin{longtable}[]{@{}lll@{}}
\toprule
Variable & mean & sd\tabularnewline
\midrule
\endhead
Age & 43.07 & 24.81\tabularnewline
Female & 0.59 & 0.49\tabularnewline
Nonwhite & 0.11 & 0.31\tabularnewline
Hispanic & 0.06 & 0.23\tabularnewline
Self-pay & 0.22 & 0.41\tabularnewline
Medicare & 0.14 & 0.35\tabularnewline
Medicaid & 0.10 & 0.30\tabularnewline
Private/Commercial & 0.37 & 0.48\tabularnewline
Other government insurance & 0.02 & 0.15\tabularnewline
HMO/prepaid plan & 0.15 & 0.36\tabularnewline
Specialist & 0.68 & 0.46\tabularnewline
Northeast & 0.23 & 0.42\tabularnewline
Midwest & 0.25 & 0.44\tabularnewline
South & 0.28 & 0.45\tabularnewline
West & 0.24 & 0.43\tabularnewline
\bottomrule
\end{longtable}

Notes: Data source: NAMSC91. Sample size is 29,854. Sample size differs
as we use data from a different year. However, the public data from 1989
(the one Hellerstein uses) allow for reproduction of Table 1. For
further information see Table 1 notes in Hellerstein (1998); With the
specifications stated in the manuscript, we cannot reproduce table 1
completely.

\hypertarget{table-2}{%
\subsubsection{Table 2}\label{table-2}}

For the first two columns, we repeat the procedure of Table 1 using the
NAMCSd data. For the third column, we compute the mean of the generic
indicator for all subpopulations defined by the dummies (Section
@ref(A2)).

\textbf{Hellerstein Table 2 - Summary Statistics for Patients in NAMCS
Drug Sample}

\begin{longtable}[]{@{}llll@{}}
\toprule
& Mean & Standard Deviation & Proportion Generic\tabularnewline
\midrule
\endhead
Age & 43.79 & 25.13 &\tabularnewline
Female & 0.59 & 0.49 & 0.27\tabularnewline
Nonwhite & 0.12 & 0.32 & 0.34\tabularnewline
Hispanic & 0.06 & 0.24 & 0.33\tabularnewline
Self-Pay & 0.27 & 0.44 & 0.29\tabularnewline
Medicare & 0.15 & 0.36 & 0.21\tabularnewline
Medicaid & 0.11 & 0.31 & 0.32\tabularnewline
Private/Commercial & 0.33 & 0.47 & 0.27\tabularnewline
HMO/prepaid plan & 0.15 & 0.35 & 0.34\tabularnewline
Specialist & 0.60 & 0.49 & 0.26\tabularnewline
Northeast & 0.21 & 0.41 & 0.28\tabularnewline
Midwest & 0.27 & 0.44 & 0.27\tabularnewline
South & 0.29 & 0.46 & 0.25\tabularnewline
West & 0.23 & 0.42 & 0.35\tabularnewline
Full sample & & & 0.28\tabularnewline
\bottomrule
\end{longtable}

Notes: The sample size is 7,715. For further notes see Hellerstein
(1998), Data source: NAMSCd91.

\hypertarget{table-3}{%
\subsubsection{Table 3}\label{table-3}}

Using the summary statistics command, we count the number of
observations for the full sample and for each of the eight defined drug
classes. We compute the mean of the generic indicator in the full sample
and each drug class subsample (Section @ref(A2)).

\textbf{Hellerstein Table 3 - Frequency of Generic Prescription by Drug
Class}

\begin{longtable}[]{@{}lll@{}}
\toprule
& Observations & \% Generics\tabularnewline
\midrule
\endhead
All drugs & 7715 & 28.37\tabularnewline
& &\tabularnewline
By drug class & &\tabularnewline
Antimicrobials & 2955 & 40.37\tabularnewline
Cardiovascular-renals & 1344 & 16.15\tabularnewline
Central Nervous System & 789 & 25.48\tabularnewline
Hormones/Hormonal mechanisms & 917 & 35.66\tabularnewline
Skin/Mucous membrane & 530 & 9.06\tabularnewline
Ophthalmics & 295 & 13.90\tabularnewline
Pain relief & 634 & 21.29\tabularnewline
Respiratory tract & 251 & 10.76\tabularnewline
\bottomrule
\end{longtable}

\hypertarget{figure-1}{%
\subsubsection{Figure 1}\label{figure-1}}

For each physician, we compute the mean of the generic indicator and
drop duplicate observations per physician. This way, every physician has
a unique observation with a respective share of generic prescriptions
(Section @ref(A2)). To approximate the distribution shown in Figure 1,
we chose the following specifications based on visual approximation
like:

\begin{itemize}
\tightlist
\item
  The decimal places at which the average generic share was rounded:
  \(.01\)
\item
  The bandwidth: \(0.02\)
\item
  The kernel function: bilinear form
\end{itemize}

\begin{figure}

{\centering \includegraphics[width=1\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/Hellerstein_Fig_1} 

}

\caption{Hellerstein Figure 1 - Distribution of Physician Generic Prescription Rates (Source: NAMSCd91)}\label{fig:HellFig1}
\end{figure}

\hypertarget{figure-2}{%
\subsubsection{Figure 2}\label{figure-2}}

We only keep physicians that prescribe the same multisource drug to at
least six patients, independent of whether it is in its generic or
trade-name form. We compute the mean of the generic share for each
remaining physician and create a categorical variable on whether this
mean is 0, indicating only trade-name drugs; 1, indicating a mix of
generic and brand-name versions; or 2, indicating only generic drugs. We
plot the frequencies of these three categories across physicians in a
bar plot (Section @ref(A2)).

\begin{figure}

{\centering \includegraphics[width=1\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/Hellerstein_Fig_2} 

}

\caption{Hellerstein Figure 2 - Physician decisions by physicians who prescribe a drug to at least six patients (Source: NAMSCd91)}\label{fig:HellFig2}
\end{figure}

\hypertarget{generate-estimates-of-your-investigated-effect-using-regression-techniques-1}{%
\subsection{Generate estimates of your investigated effect using
regression
techniques}\label{generate-estimates-of-your-investigated-effect-using-regression-techniques-1}}

Hellerstein applies a random effects probit regression model aggregated
on physician level. The parameterization of the model is implemented as
follows:

\textbf{Dependent variable (\(Y\))}

\begin{itemize}
\tightlist
\item
  \(G\): \emph{Generic compared to brand-name drug use}
\end{itemize}

\emph{Note that Hellerstein uses a somewhat different notation for the
outcome variable which is denoted as \(G\). Today, it is often common to
denote this variable by \(Y\).}

\textbf{Variable of interest or treatment (\(X\))}

\begin{itemize}
\tightlist
\item
  \(P\): \emph{Insurance status by: Medicare, Medicaid, HMO/prepaid,
  private insurance, self-paid (this is the omitted category).}
\end{itemize}

\emph{Note that Hellerstein (1998) uses a somewhat different notation
for the variable of interest which is denoted as \(P\). Today, it is
often common to denote this variable by \(X\) or \(D\). Though for the
purpose of the reproduction and to avoid confusion we take on
Hellerstein's notation in the following.}

\textbf{Confounders \(Z\) of the effect of insurance status \(P\) and
generic vs brand-name drug use \(Y\).}

\begin{itemize}
\tightlist
\item
  \(C\): \emph{Drug class identifiers among 8 classes (Pain relief
  (omitted), see footnote Table 5)}
\item
  \(X\): \emph{Patient characteristics: age, sex, race}
\item
  \(S\): \emph{Physician specialist status: Specialist, general
  practitioner (omitted)}
\item
  \(R\): \emph{Region as classified by: Midwest, South, West, Northeast
  (omitted)}
\item
  Vector \(X\) \emph{Average patient characteristics in one practice}
\item
  Vector \(P\): \emph{Average of a physician's patients in each
  insurance category}
\end{itemize}

\emph{Note that Hellerstein uses a somewhat different notation for
confounding variables. It is often common to denote the variable of
interest using the index \(X\), but not necessarily confounders.}

\hypertarget{tables-4-and-5}{%
\subsubsection{Tables 4 and 5}\label{tables-4-and-5}}

We estimate the regression coefficients, t-statistics and marginal
effects of the regression model. It is not indicated whether the model
for both tables contain all covariates specified in equation 10 or just
the variables mentioned in the tables. We decide to use the full model
for both tables. Marginal effects are the average marginal effects
across individuals (footnote Table 4) (Section @ref(A3)).

\textbf{Hellerstein Table 4 - Estimated Coefficients on Demographic
Variables, Geographic Variables, and Average Characteristics for Full
Sample, excluding regional identifiers}

\begin{longtable}[]{@{}lllll@{}}
\toprule
& Random-Effects Probit Coefficient & & \% Change in Generic
&\tabularnewline
\midrule
\endhead
Constant & -0.556** & (-3.17) & &\tabularnewline
Age & -0.002* & (-1.99) & -0.001* & (-1.99)\tabularnewline
Female & -0.112** & (-2.94) & -0.028** & (-2.94)\tabularnewline
Hispanic & 0.025 & (0.28) & 0.006 & (0.28)\tabularnewline
Nonwhite & 0.044 & (0.62) & 0.011 & (0.62)\tabularnewline
Specialist & 0.019 & (0.25) & 0.005 & (0.25)\tabularnewline
Mean age & -0.003 & (-1.10) & -0.001 & (-1.10)\tabularnewline
Percent female & -0.189 & (-1.16) & -0.048 & (-1.16)\tabularnewline
Percent black & 0.075 & (0.41) & 0.019 & (0.41)\tabularnewline
Percent Hispanic & -0.112 & (-0.45) & -0.028 & (-0.45)\tabularnewline
Percent Medicaid & 0.062 & (0.26) & 0.016 & (0.26)\tabularnewline
Percent Medicare & -0.155 & (-0.71) & -0.039 & (-0.71)\tabularnewline
Percent private insured & 0.155 & (1.08) & 0.039 & (1.08)\tabularnewline
Percent HMO/prepaid & 0.054 & (0.30) & 0.014 & (0.30)\tabularnewline
Midwest & -0.141 & (-1.53) & -0.036 & (-1.53)\tabularnewline
South & -0.206* & (-2.28) & -0.052* & (-2.29)\tabularnewline
West & 0.065 & (0.67) & 0.016 & (0.67)\tabularnewline
\bottomrule
\end{longtable}

Notes: \(*p < 0.05, **p < 0.01, ***p < 0.001\); The sample size is
7,715. For further notes see Hellerstein (1998); Data source: NAMSCd91.

Table 5 shows the estimated coefficients for the eight largest drug
classes as well as the \% change in the generic share. The greatest
change compared to Hellerstein (1998) is the change in sign from
positive to negative for cardiovascular/renals, though not significant
in our model.

\textbf{Hellerstein Table 5 - Estimated Coefficients for Drug-Class
Dummy Variable for Full Sample}

\begin{longtable}[]{@{}lllll@{}}
\toprule
& Random-Effects Probit Coefficient & & \% Change in Generic
&\tabularnewline
\midrule
\endhead
main & & & &\tabularnewline
Antimicrobials & 0.628*** & (8.47) & 0.159*** & (8.54)\tabularnewline
Cardiovascular-renals & -0.147 & (-1.71) & -0.0371 &
(-1.71)\tabularnewline
Central Nervous System & 0.0559 & (0.58) & 0.0141 &
(0.58)\tabularnewline
Hormones/Hormonal mechanisms & 0.584*** & (6.92) & 0.148*** &
(6.95)\tabularnewline
Skin/Mucous membrane & -0.731*** & (-6.26) & -0.185*** &
(-6.28)\tabularnewline
Ophthalmics & -0.383* & (-2.47) & -0.0968* & (-2.47)\tabularnewline
Resperatory tract & -0.675*** & (-4.79) & -0.171*** &
(-4.80)\tabularnewline
\bottomrule
\end{longtable}

Notes: \(*p < 0.05, **p < 0.01, ***p < 0.001\); The sample size is
7,715. Omitted category is pain relief. For further notes see
Hellerstein (1998); Data source: NAMSCd91.

\hypertarget{table-6}{%
\subsubsection{Table 6}\label{table-6}}

We run a separate regression using only observations of a single drug
class and report the coefficients of the payment dummies and their
average marginal effects (Section @ref(A2)).

\textbf{Hellerstein Table 6 - Tests for Moral Hazard for the Full Sample
Equality of Individual Insurance Variables with Self-Payment
Random-Effects Probit Results}

\begin{longtable}[]{@{}lllllllllllllllll@{}}
\toprule
\begin{minipage}[b]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[b]{0.04\columnwidth}\raggedright
Antimicrobial\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage} & \begin{minipage}[b]{0.04\columnwidth}\raggedright
Cardiovasculars\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage} & \begin{minipage}[b]{0.05\columnwidth}\raggedright
Central Nervous System\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
Hormones\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage} & \begin{minipage}[b]{0.05\columnwidth}\raggedright
Skin/Muchous Membranes\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
Ophthalmics\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage} & \begin{minipage}[b]{0.04\columnwidth}\raggedright
Pain relief\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage} & \begin{minipage}[b]{0.04\columnwidth}\raggedright
Respiratory Tract\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage}\tabularnewline
\midrule
\endhead
\begin{minipage}[t]{0.03\columnwidth}\raggedright
Medicaid\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
Coefficient\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.14\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.04\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.00\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.00\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.02\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.00\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.38\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.08\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.03\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.00\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.25\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.05\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.54\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.08\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-1.21\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.09\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
1.12\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
1.13\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.02\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.02\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.08\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.08\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
1.23\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
1.23\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.04\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.04\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.60\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.60\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
1.12\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
1.15\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-1.08\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-1.11\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
Medicare\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
Coefficient\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.11\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.03\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.05\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.01\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
-0.32\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.06\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.42\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.09\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.54\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.05\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.41\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.08\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.08\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.01\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.60\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.05\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.72\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.72\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.25\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.25\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
-1.13\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-1.12\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-1.68\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-1.69\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.89\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.90\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.97\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.97\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.18\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.18\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.67\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.68\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
Private\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
Coefficient\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.00\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.00\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.06\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.01\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
-0.06\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.01\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.16\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.03\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.03\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.00\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.31\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.06\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.18\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.03\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-1.27\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.10\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.01\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.01\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.30\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.30\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
-0.28\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.28\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.75\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.75\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.07\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.07\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.91\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.91\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.51\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.51\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-1.45\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-1.56\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
HMO/Prepaid\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
Coefficient\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.22\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.06\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.14\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.03\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.32\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.06\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.33\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.07\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
-0.42\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.04\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.57\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.11\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.28\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.04\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.26\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.02\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
1.78\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
1.78\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.56\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.56\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
1.04\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
1.05\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-1.09\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-1.09\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
-0.73\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.73\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.93\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.93\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.71\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.72\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.26\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.25\strut
\end{minipage}\tabularnewline
\bottomrule
\end{longtable}

Notes: see Hellerstein (1998); Data source: NAMSCd91.

\hypertarget{tables-7-8-and-9}{%
\subsubsection{Tables 7, 8 and 9}\label{tables-7-8-and-9}}

These tables cannot be reproduced as the publicly available data of
NACMSd do not provide variables to identify physicians and patients by
region.

\hypertarget{report-study}{%
\chapter{Reporting the Study}\label{report-study}}

\hypertarget{basic-steps-to-reporting-the-study}{%
\section{Basic steps to reporting the
study}\label{basic-steps-to-reporting-the-study}}

\begin{center}\includegraphics[width=1\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/hannah-grace-j9JoYpaJH3A-unsplash-edit} \end{center}

\emph{``Figure out the one central and novel contribution of your paper.
Write this down in one paragraph.''} (Cochrane
\protect\hyperlink{ref-cochrane_writing_2005}{2005}, 1)

At this stage you need to report all your performed work in detail in a
scientific research paper.

When reporting the study you should provide readers with the necessary
information to reproduce every table and figure; to assess the
appropriateness of methods used, given your settings and data, and its
contribution and conclusions, given your results.

A research paper usually includes the following sections:

\begin{itemize}
\tightlist
\item
  Title
\item
  Abstract
\item
  Introduction
\item
  Previous Literature
\item
  Background (optional)
\item
  Data and Variables
\item
  Empirical Methods
\item
  Results
\item
  Discussion
\item
  Summary and Conclusion
\item
  References
\item
  Appendices
\end{itemize}

We briefly summarize each of these items, based on Cochrane
(\protect\hyperlink{ref-cochrane_writing_2005}{2005}), Dudenhefer
(\protect\hyperlink{ref-dudenhefer_guide_2014}{2014}),
\href{https://www.youtube.com/watch?v=Vky9PDKx5KU}{Martin, 2018}, and
Plamen (\protect\hyperlink{ref-plamen_writing_2020}{2020})):

\begin{figure}

{\centering \includegraphics[width=1\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/comics} 

}

\caption{How to report your paper}\label{fig:writepaper}
\end{figure}

Source:
\url{https://towardsdatascience.com/how-to-keep-your-research-projects-organized-part-1-folder-structure-10bd56034d3a}

The \textbf{Title} should be short (15 words or less) and reflect your
research question. It usually contains the purpose (what is the question
you are addressing?) and scope (if you cover a specific time period or
population) of the study. You might also include the methods of your
study in the title, if, e.g., you conduct a cohort study. All this
information should help readers to decide whether or not they are
interested in reading the paper.

The \textbf{Abstract} is usually around 150 words or less and includes a
very short summary of your research question, main contribution, data
and methods used, main findings, and conclusions.

The \textbf{Introduction} is the most important part of the paper as it
has to grab the readers' attention. It should motivate your research
topic and give a more extensive overview of the context, data, methods
and findings. You provide context by referencing the existing literature
regarding what we know and what we do not know about the topic. You
parlay the latter part into your research question. An important aspect
of introduction is to highlight what contribution your paper makes, and
how it relates to and improves previous work on the topic.

You need to raise the interest of your readers to a degree that they
would want to continue reading the rest of your paper. Therefore, it is
advisable that you write this section at the very end.

It should be structured as a newspaper article -- where you first
deliver the main message and information, and then provide details --
rather than a novel- -- where you first build up the narrative and only
reach the story punchline at the very end.

At the end of this section you could write a roadmap that briefly guides
the reader through your paper. Overall, the whole section should not
take up more than 3 pages.

Once you choose your topic and pose a research question, the first thing
you usually do is look at the related previous literature. The
\textbf{Previous literature} review is a standard in economic papers and
constitutes a significant part of your empirical project. It is either
included in the \textbf{Introduction} or is placed in a separate
section.

The main purpose of the review is to show the reader that you are
familiar with the main scholarly work in the field; to critically review
the most relevant and influential (well-cited) studies on the topic; to
place your study in the context of other studies; and to convince the
reader of the need to conduct the research in question, and to show how
it fits into and contributes to the study field (Are you using new data
or identification strategy? Are you answering a question more
specifically? How are you improving on previous papers?).

It helps you to establish whether the topic has been researched before,
to identify limitations of previous research and still open research
gaps. You do not need to mention every published paper on the topic, but
you do need to cite the most important studies in the area and
distinguish your paper from them. Literature reviews are selective: you
only include papers that are relevant for your argument.

Importantly, a literature review should not simply consist of a series
of paragraphs that summarize papers in no particular order. Instead, a
good iterature review should be carefully constructed to tell a specific
story: this is what others have done on my topic; this is what is
unsatisfactory or missing from that research; and here is how I am going
to fill this researh gap. Thus, through your literature review you
``sell'' the value addded of your paper.

In a literature review, you need to identify and summarize key scholarly
publications from the fields that are pertinent to your research topic.
It should involve a thorough search of the main key words in the
relevant databases and journals. To organize your literature search, you
can create a spreadsheet, where you include study and author(s) names,
publication journal and year, identification strategy, main resuts,
caveats and comments. Always take notes on the papers you read. This
will help you to summarize and organize your review once you are ready
to write it.

Sometimes a paper might contain a \textbf{Background} section that
provides background information about a historical event or context, a
specific country's health care system, or details about a specific
policy or program in question.

The \textbf{Data and Variables} section should contain a detailed
information about the data sources used in the paper as well as
information about the variables used in the analysis. Identify your data
sources and describe them, i.e.~data-generating process, the unit and
the number of observations, the population groups sampled, the time
period during which the data were collected, the method of data
collection, type of data (cross-sectional, panel, time series), main
variables for your reseaarch question, etc. Mention any data limitations
that might influence your results, i.e.~small number of observations,
survey response, missing observations, attrition or selection bias, over
or underrepresentation of certain populations, etc.

Describe your sample and variable selection in great detail: how you
construct your sample and which data manupulations you perform. Provide
descriptive statistics and graphs. Descriptive statistics usually
includes means and standard deviations of variables you use in your
analysis. Sometimes you need to present this statistics for different
subgroups, e.g., treatment and control, post and pre treatment. Point
here to the patterns that are easily observable from the summary
statistics that can help the reader better understand your analysis.

Generally, a good way to learn how to write a data section is to look in
the related literature and pay attention to the information it includes.

The \textbf{Empirical method} section should in great detail describe
the statistical method used in the paper and the assumptions that are
necessary to be fulfilled in order to get an unbiased and consistent
estimation of your parameter of interest. Write whether you weight the
data or use certain fixed effects. Also describe the empirical problems
and how you address them. Ideally, you should describe each step that
readers should perform, if they would like to reproduce your results and
conclusions.

You need to explain the appropriatness of the method you choose for the
specific context. You need to write down your econometric equation and
explain how variables are defined and measured. Mention key parameters
of interest.

The \textbf{Results} section should contain a set of tables and figures
that show your main empirical results. Make sure that tables are
reader-friendly and are easy to comprehend. Place figures and tables as
close as possible to the place in the text where you first refer to
them. Do not report all the variables incuded in the regression, but
only present the results and parameters that directly relate to your
main hypothethis and story. Including too namy parameters and results
can distract the readers from your main point. Thus, guide the readers
and focus their attention only on the most important results from your
anaylsis and in the right order.

Do not provide any interpretations or speculations here. Keep it factual
and simply describe in words what the tables and figures display.
Comment on the economic significance of your results, not just their
statistical significance. After the main results, discuss potential
biases and shortcoming to the internal validity and suggest ways to
check them. Place secondary results and your response to potential
criticisms and robustness checks into your Appendix.

The \textbf{Discussion} section contains the interpretation and
discussion of the results, as well as potential mechanisms, and suggests
a direction for future research.

Start your discussion by reiterating your research question and, based
on your findings, state what you think an answer to your question is. Do
not introduce any new data or results in this section. It should reflect
only the results already presented in the paper. Interpret your results
in the context of the literature that you identify and discuss in the
\textbf{Introduction} and the \textbf{Previous Literature} sections (Are
your findings consistent with what the other literature has found? Do
your data fill the gap in the knowledge that you identify?). Here you
want to show how your work adds to and extends the knowledge on the
topic.

You can also discuss implications of your study for public policy. You
also should acknowledge and discuss the limitations of the study here
and what implications these limitations might have for the results. The
more accurate, open and detailed you are about the limitations, the more
credibility your results will have. Suggest alternative interpretations
and other possible mechanisms that can explain your findings. You can
also talk about next steps and the implications of your findings for
future research.

The \textbf{Summary and Conclusion} section should be short and sweet (a
few concise paragraphs). It contains the most important information on
the topic, findings and concluding remarks. It should mirror main points
mentioned in the \textbf{Introduction}. You should underline why your
research matters and state the answer to your research question. Also
state here any recommendations that can be made based on your findings.

At the very end of your paper you need to provide a complete list of
\textbf{References}. The bibliography includes a compete list of
academic papers and books referenced and cited in your study. Make sure
that all your in-text citations appear in the Reference list at the end
of the paper.

The easiest way to keep track of your reference list is to write down
the information, i.e.~the title, author(s), journal/book, publisher, and
publication date, about the original source each time you use it. Decide
in advance on one citation and reference style and follow it
consistently throughout the paper.

The \textbf{Appendices} are a handy tool that allows you to save space.
As a careful researcher you will conduct a series of robustness checks
of your main results. However, once you confirm that the results are
stable, to keep your paper focused and not too long you can move all the
still relevant, but secondary and less critical information in
appendices. You should summarize what you did in the main body of your
paper and include an in-text reference to the information in the
appendix. Most journals provide possibilities of an online appendix or
supplementary material.

\begin{figure}

{\centering \includegraphics[width=0.8\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/paperstructure} 

}

\caption{Paper Structure}\label{fig:paper_structure}
\end{figure}

Source:
\href{http://www.fresnostate.edu/academics/gradstudies/graduatewritingstudio.html}{Fresno
State Graduate Writing Studio.}
\href{https://fresnostategraduatewritingstudio.files.wordpress.com/2015/09/elements-of-a-research-paper.pdf}{Elements
of a Research Paper.}

\hypertarget{the-writing-process-tips-based-on-cochrane_writing_2005-and-dudenhefer_guide_2014}{%
\subsection{\texorpdfstring{The writing process, tips based on Cochrane
(\protect\hyperlink{ref-cochrane_writing_2005}{2005}) and Dudenhefer
(\protect\hyperlink{ref-dudenhefer_guide_2014}{2014})}{The writing process, tips based on Cochrane (2005) and Dudenhefer (2014)}}\label{the-writing-process-tips-based-on-cochrane_writing_2005-and-dudenhefer_guide_2014}}

\begin{itemize}
\tightlist
\item
  Producing a good empirical paper takes time. You should start working
  on it and drafting it as soon as possible.
\item
  Allow yourself sufficient time for collecting and analyzing the data,
  writing and revising the paper. Writing a paper is a recursive process
  that takes many revisions.
\item
  Read the text yourself and let others read it. (\emph{``Is the text
  interesting to read?''}, \emph{``Would you want to read beyond the
  introduction yourself?''})
\item
  Shorter is better: keep the paper short as possible. Every word must
  count. When editing always ask yourself whether you can make the same
  point with fewer words.
\item
  Avoid repetition. It uses extra space and tests readers' patience. If
  it is possible to cut a word, sentence or paragraph, then cut them
  out.
\item
  Keep track of your resources as you work on your ideas. Do not rely on
  your memory when you come across information you might use in your
  paper. Invest in acurate note-keeping from the start. It will save you
  time and extra work when you draft your paper.
\item
  Pay attention to the writing style in the papers you read and admire;
  carefully analyze what information they contain and how they put it
  together.
\item
  Remember, no one can learn to write simply by reading a few manuals
  and tips on the topic. You can only do it by practicing.
\end{itemize}

More principles on writing in economics are summarized in
\href{http://www3.nccu.edu.tw/~jthuang/rules.html}{Top Ten Rules of
Economical Writing} and more comprehensively in McCloskey and Ziliak
(\protect\hyperlink{ref-mccloskey_economical_2019}{2019}) and by Hall
(\protect\hyperlink{ref-hall_how_2013}{2013}).

\hypertarget{general-guidance-on-writing-and-use-of-language-in-a-research-paper}{%
\subsection{General guidance on writing and use of language in a
research
paper}\label{general-guidance-on-writing-and-use-of-language-in-a-research-paper}}

These tips are a collection of Cochrane
(\protect\hyperlink{ref-cochrane_writing_2005}{2005}),
\href{https://www.awelu.lu.se/language/register-and-style/dos-donts/}{Lund
University}, and Plamen
(\protect\hyperlink{ref-plamen_writing_2020}{2020}).

\begin{itemize}
\tightlist
\item
  Do not use slang, jargon, or colloquialisms. Always use formal
  language.
\item
  Do not use common vocabulary, such as \emph{have got, the other
  thing}. Make more formal vocabulary choices, e.g., \emph{have
  found,~the other issue/problem/notion/idea etc..}
\item
  Do not use shortened verb forms, such as \emph{they're, isn't, can't,
  don't}. Use the full verb form instead, e.g., \emph{they are, is not,
  cannot.}
\item
  Do not use subjective language, i.e.~\emph{I think, we assume.} Use
  objective language.
\item
  Avoid using past or future tenses. Use present tense and generally
  stick to one tense: \emph{``This paper attempts to\ldots{}''},
  \emph{``Hellerstein (1998) finds that\ldots{}''}; \emph{``Table 1
  shows\ldots{}''}
\item
  Do not use passive voice, i.e.~\emph{It has been shown in the paper by
  Hellerstein (1998).} Use active voice, i.e.~\emph{Hellerstein (1998)
  shows\ldots{}}
\item
  Do not use needless words and information that clutter the writing.
  Use simple and direct sentences, and keep them short. For example,
  change \emph{``in order to'' to ``to'', ''whether or not'' to
  ``whether'', ``is equal to'' to ``equals'', ``it should be noted'' to
  ``notably''.}
\item
  Place minor or secondary details and digressions from the main text
  into footnotes, but use them sparingly.
\item
  Use ``I'' in a single-author project, and ``we'' in the project with
  more than one author.
\item
  Do not plagiarize. Provide references and citations whenever you say
  something that is not your own. Proper referencing and citations
  prevent acusations of plagiarisms, allow to acknowledge your sources,
  give credibility to your work, and demostrate your knowledge in the
  subject area.
\item
  Use in-text citations: \emph{``Hellerstein (1998) finds
  that\ldots{}''} Do not write \emph{``Judith Hellerstein in 1998
  journal article finds that\ldots{}''}
\item
  Do not mix British and American English, citation styles, tenses, and
  different word spellings (e.g., health care vs healthcare, data set vs
  dataset, policy makers vs policymakers, socio-economic vs
  socioeconomic, etc.). Be consistent in the use of language and style.
\item
  Remember that ``long-run'' as an adjective uses hyphen, while ``long
  run'' as a noun does not.
\item
  Use automatic spellcheck, but never rely on it completely. Always
  double check for tricky words and proofread the text. Ask others to
  read it.
\item
  Do not get complacent after finishing the first draft of the
  manuscript. Revise, rewrite, polish, carefully proofread and
  spellcheck. Control the word count.
\item
  Read a copy of
  \href{http://www.jlakes.org/ch/web/The-elements-of-style.pdf}{Strunk,
  W. Jr \& White E. B. (1972). The Elements of Style} and
  \href{https://www.google.com/url?sa=t\&rct=j\&q=\&esrc=s\&source=web\&cd=\&ved=2ahUKEwiCztfjrsr0AhXvR_EDHU3aAYsQFnoECA4QAQ\&url=https\%3A\%2F\%2Fteamwork.jacobs-university.de\%2Fdownload\%2Fattachments\%2F49185212\%2Fon-writing-well.pdf\%3Fversion\%3D1\%26modificationDate\%3D1527540932000\%26api\%3Dv2\&usg=AOvVaw3eFZJabrSvWpKo5WxCAS6t}{Zinsser,
  W. (2001). On Writing Well}.
\end{itemize}

\hypertarget{tables-tips-based-on-cochrane_writing_2005}{%
\subsection{\texorpdfstring{Tables, tips based on Cochrane
(\protect\hyperlink{ref-cochrane_writing_2005}{2005})}{Tables, tips based on Cochrane (2005)}}\label{tables-tips-based-on-cochrane_writing_2005}}

\begin{itemize}
\tightlist
\item
  Each table should be self-explanatory. Give your variables in the
  table self-explanatory names.
\item
  Use 2 to 4 digits after the comma when reporting the results, not all
  the numbers produced by the statistical program. Apply this rule
  consistently for all the tables in your paper.
\item
  Show results with and without controls. For example, start with a
  column that includes only the main coeffitient(s) of interest and then
  progressively inlcude various controls (e.g., patient characteristics,
  hospital/physician fixed effects, etc.) in subsequent columns.
\item
  Include standard errors together with your coefficients.
\item
  Indicate the source of the data at the bottom.
\end{itemize}

\hypertarget{figures-tips-based-on-cochrane_writing_2005}{%
\subsection{\texorpdfstring{Figures, tips based on Cochrane
(\protect\hyperlink{ref-cochrane_writing_2005}{2005})}{Figures, tips based on Cochrane (2005)}}\label{figures-tips-based-on-cochrane_writing_2005}}

\begin{itemize}
\tightlist
\item
  Use figures to show patterns in the data -- they demonstrate it better
  than tables with numbers,
\item
  Label the axes properly,
\item
  Add clear legends,
\item
  Do not color your figures since some readers will view/print your
  paper in the black-and-white mode,
\item
  Provide self-explanatory captions,
\item
  Indicate the source of the data at the bottom.
\end{itemize}

\hypertarget{resources-box-5}{%
\section{Resources box}\label{resources-box-5}}

\hypertarget{collections-of-writing-tips-and-short-articles}{%
\subsection{Collections of writing tips and short
articles}\label{collections-of-writing-tips-and-short-articles}}

\begin{itemize}
\tightlist
\item
  Dudenhefer, P. (2014).
  \href{https://econ.duke.edu/sites/econ.duke.edu/files/file-attachments/Dudenhefer\%2C\%20Paul\%20-\%20Guide\%20to\%20Writing\%20in\%20Economics.pdf}{A
  guide to Writing in Economics. EcoTeach Center and Department of
  Economics, Duke University.}
\item
  Plamen, N. (2020).
  \href{https://mpra.ub.uni-muenchen.de/105088/1/MPRA_paper_105088.pdf}{Writing
  tips for economics research papers}
\item
  \href{https://www.johnhcochrane.com/}{Cochrane, J. H.} (2005).
  \href{http://mayoral.iae-csic.org/timeseries_bgse13/phd_paper_writing.pdf}{Writing
  tips for Ph.D.~students.} Chicago, IL: University of Chicago.
\item
  \href{http://www3.nccu.edu.tw/~jthuang/rules.html}{Top Ten Rules of
  Economical Writing}
\end{itemize}

\hypertarget{books}{%
\subsection{Books}\label{books}}

\begin{itemize}
\tightlist
\item
  Hall, G. M. (Ed.). (2013).
  \href{https://onlinelibrary.wiley.com/doi/book/10.1002/9781118488713}{How
  to write a paper (5th ed). Wiley-Blackwell.}
\item
  McCloskey, D. N., \& Ziliak, S. T. (2019). Economical Writing, Third
  Edition: Thirty-Five Rules for Clear and Persuasive Prose (Third
  Edition). University of Chicago Press.
\item
  Strunk, W. Jr \& White E. B. (1972).
  \href{http://www.jlakes.org/ch/web/The-elements-of-style.pdf}{The
  Elements of Style} - great general writing style book
\item
  Zinsser, W. (2001).
  \href{https://www.google.com/url?sa=t\&rct=j\&q=\&esrc=s\&source=web\&cd=\&ved=2ahUKEwiCztfjrsr0AhXvR_EDHU3aAYsQFnoECA4QAQ\&url=https\%3A\%2F\%2Fteamwork.jacobs-university.de\%2Fdownload\%2Fattachments\%2F49185212\%2Fon-writing-well.pdf\%3Fversion\%3D1\%26modificationDate\%3D1527540932000\%26api\%3Dv2\&usg=AOvVaw3eFZJabrSvWpKo5WxCAS6t}{On
  Writing Well}
\end{itemize}

\hypertarget{videos}{%
\subsection{Videos}\label{videos}}

\begin{itemize}
\tightlist
\item
  \href{https://www.youtube.com/watch?v=Vky9PDKx5KU}{Martin, G. (2018).
  How to write a paper.}
\end{itemize}

\hypertarget{online-resource}{%
\subsection{Online resource}\label{online-resource}}

\begin{itemize}
\tightlist
\item
  \href{https://www.awelu.lu.se/language/register-and-style/dos-donts/}{Lund
  University. Academic Writing in English.}
\end{itemize}

\hypertarget{checklist-to-reporting-the-study}{%
\section{Checklist to reporting the
study}\label{checklist-to-reporting-the-study}}

\begin{itemize}
\tightlist
\item
  Start writing early. Edit your text a lot to improve it.
\item
  Make sure you follow your one central research question.
\item
  Ensure you cover and include all relevant sections of a research
  paper.
\item
  Concentrate on the most important tables and figures for your main
  text.
\item
  Plan ahead for proof-reading and editing the text you have written.
\item
  Be able you read your own paper with some time distance.
\end{itemize}

\hypertarget{example-hellerstein-1998-4}{%
\section{Example: Hellerstein (1998)}\label{example-hellerstein-1998-4}}

We go over each section of the manuscript to highlight its role to
Hellerstein's research article. The structure contains the following
parts:

\begin{itemize}
\item
  Title
\item
  Abstract
\item
  Introduction
\item
  Background and related literature

  \begin{itemize}
  \tightlist
  \item
    Medical
  \item
    Legal
  \item
    Institutional
  \end{itemize}
\item
  Empirical motivation and summary statistics
\item
  The model
\item
  Empirical implementation
\item
  Estimation results
\item
  Conclusion
\item
  Appendices
\item
  References
\end{itemize}

\hypertarget{title}{%
\subsection{Title}\label{title}}

The paper title consists of 12 words that reflect the paper's research
question.

\hypertarget{abstract}{%
\subsection{Abstract}\label{abstract}}

In the abstract Hellerstein gives a short overview on the paper by
mentioning the topic, the data, the results and their takeaway.

\hypertarget{introduction}{%
\subsection{Introduction}\label{introduction}}

The introduction to the study is short. Hellerstein starts it by
highlighting a welfare-enhancing potential of substituting trade-name
drugs with generics, creating relevance for her topic. Next, she
elaborates her research question, followed by a short overview of the
results and their implications. She finalizes with a structural overview
of the rest of her paper.

Other common features of an introduction are missing here. These include
an overview of the pre-existing research, contribution to different
fields in the literature, and an overview of the methodological
approach.

\hypertarget{background-and-related-literature}{%
\subsection{Background and related
literature}\label{background-and-related-literature}}

The background section is divided into three parts:

\begin{itemize}
\tightlist
\item
  A quick summary on the history of generics
\item
  An overview of different legal systems around generic prescription and
  generic substitution
\item
  An institutional background, that includes:
\item
  A discussion on the decision situation physicians face
\item
  A list of health insurance types with their respective coverage of
  prescription drugs.
\end{itemize}

By providing these background information Hellerstein familiarizes her
readers with key aspects of her topic and creates further relevance for
her research. She uses descriptive statistics on generic prescription
and substitution laws for different legal systems to justify her
approach to include geographical covariates in her analysis.
Analogously, she argues for the importance to consider the type of
insurance by discussing differences between these insurance systems,
especially with regard to coverage rates.

\hypertarget{empirical-motivation-and-summary-statistics}{%
\subsection{Empirical motivation and summary
statistics}\label{empirical-motivation-and-summary-statistics}}

Hellerstein uses this chapter for two things: to introduce her sample
and to show heterogeneities in generic prescription rates in her sample.
The first part of the chapter is thereby built as follows:

\begin{itemize}
\tightlist
\item
  An introduction of the raw data
\item
  An elaboration on data clearing processes
\item
  A descriptive overview on the patient sample (NAMCS) and the
  drug-level subsample (NAMCSd). The variables used for descriptive
  statistics will later reappear as covariates in the analysis.
\end{itemize}

The data introduction helps readers to understand the sample Hellerstein
uses for her analysis; how it originates, what its properties are and
how valid it might be for this particular research topic. The remaining
part of the chapter emphasises on descriptive differences in generic
prescription rates. The heterogeneities Hellerstein focusses on are in
particular:

\begin{itemize}
\tightlist
\item
  In generic prescription rates across drug classes.
\item
  How frequent physicians prescribe generics.
\item
  Whether physicians prescribe the same medication sometimes as generic
  and sometimes as trade-name version, or whether they stick with one
  option all the time. These patterns lay the foundation on why her
  empirical analysis is important. Further, the statistics in this
  chapter introduce and justify the inclusion of covariates in her
  model.
\end{itemize}

\hypertarget{the-model}{%
\subsection{The model}\label{the-model}}

Hellerstein clarifies from a theoretical perspective, what factors might
determine a physician's decision to prescribe a generic. Beyond
clarifying the decision situation Hellerstein's analysis revolved around
the model also serves as a hypothesis for her research question. In the
formula, it is clearly defined when the insurance coverage (that closely
correlates with the insurance status) nudges a physician towards
prescribing a generic. Last, the model serves as an additional argument,
what variables should be considered when empirically modelling the
behavior of physicians.

\hypertarget{empirical-implementation}{%
\subsection{Empirical implementation}\label{empirical-implementation}}

In the first part of this chapter, Hellerstein elaborates how her theory
lays framework for empirical application. Most parameters of her
theoretical model are not included in the NAMCS data. She therefore
discusses how to proxy missing elements using available variables. Next,
she introduces her empirical model. First, she describes all variables
and variable vectors that are included. Next, she discusses her choice
of using a random effects estimator. The chapter concludes with a
discussion of limitations and possible extensions to her empirical
approach.

\hypertarget{estimation-results}{%
\subsection{Estimation results}\label{estimation-results}}

In the results chapter, Hellerstein again describes her regression model
and presents the results. Further she discusses concerns about her
estimates and uses other specifications of her model to show the
robustness of her results. Some results of the robustness tests are also
reported. The chapter starts with a re-specification of her empirical
application. It is noteworthy, that the model described here deviates
from the equation presented in the previous chapter. All estimated
coefficients of this single regression are reported in 3 separate
tables:

\begin{itemize}
\tightlist
\item
  Table 4: Coefficients of demographic variables and frequency of
  demographics per physician
\item
  Table 5: Coefficients of drug class dummies
\item
  Table 6 Coefficients of drug class x insurance type interactions.
\end{itemize}

In the text accompanying the tables, she picks numerous coefficients,
provides possible explanations, and derives implications. Hellerstein
mentions multiple limitations of her model and addresses concerns by a
number of robustness checks. These include:

\begin{itemize}
\tightlist
\item
  Using a subsample of patients below age 65.
\item
  Using a subsample of physicians with more than 20/30 patients in the
  overall NAMCS (results for both of these robustness tests are not
  reported).
\item
  Using a subsample of observations from states with a special legal
  system (these results are reported).
\item
  Hellerstein not only uses the results section to report her findings,
  but also to discuss their implications and limitations. Typically,
  this is done in a separate discussion section
\end{itemize}

\hypertarget{conclusion}{%
\subsection{Conclusion}\label{conclusion}}

Hellerstein starts her conclusion with a short summary of the research
findings:

\begin{itemize}
\tightlist
\item
  What is the aim of her analysis?
\item
  What are the key findings?
\item
  What is the takeaway?
\end{itemize}

Hellerstein then finalizes her article with a discussion on how findings
are relevant for future research and policy.

\hypertarget{appendices}{%
\subsection{Appendices}\label{appendices}}

The paper appendix consists of two parts:

\begin{itemize}
\tightlist
\item
  A methodological background on the random effects estimator
  Hellerstein uses
\item
  Additional background information on the data and the data clearing
  processes
\end{itemize}

\hypertarget{references}{%
\subsection{References}\label{references}}

Hellerstein lists all in-text references used in the paper in
alphabetical order.

\hypertarget{replication-results-of-hellerstein-1998}{%
\chapter{Replication results of Hellerstein
(1998)}\label{replication-results-of-hellerstein-1998}}

We show the results of the replication of Tables 1-3 and Figures 1-2 of
the descriptive analysis, and the replication of the empirical analysis
in Tables 4-6 in this document). Our results are based on data from 1991
which is in contrast to Hellerstein
(\protect\hyperlink{ref-hellerstein_importance_1998}{1998}) that used
three datasets from 1989. As access to confidential data is required to
identify physicians and patients in the 1989 data, we resort to 1991
that provide state identifiers in two publicly available datasets. We
present our results and discuss deviations from Hellerstein
(\protect\hyperlink{ref-hellerstein_importance_1998}{1998}). A detailed
discussion and interpretation is provided in the original study.

\hypertarget{descriptive-analysis}{%
\section{Descriptive Analysis}\label{descriptive-analysis}}

Summary statistics are shown in Table 1. They represent the sample of
patients represented in NAMCS in the year 1991. Results are similar to
the summary statistics shown by Hellerstein
(\protect\hyperlink{ref-hellerstein_importance_1998}{1998}). Some
categories of the payment sources differ slightly. Four categories --
Self-pay, Medicare, Madicaid and HMO/prepaid plan -- match. The
categories Blue Cross/ Blue Shield and Other commerical insurer seem to
have merged into the category Private/Commercial. When looking at the
distribution of insurance coverage, we see that the frequency of
patients with status \emph{Private/Commercial} perfectly adds up to the
frequencies of Blue Cross and other commercial insurers. Differences in
the distribution of other covariates are slim. The most noticable
difference lies in the share of specialist physicians, which account for
68\% of visited physicians in the 1991 sample compared to 55\% in 1989.

\textbf{Hellerstein Table 1 - Summary Statistics for Overall NAMCS
Patient Sample}

\begin{longtable}[]{@{}lll@{}}
\toprule
Variable & mean & sd\tabularnewline
\midrule
\endhead
Age & 43.07 & 24.81\tabularnewline
Female & 0.59 & 0.49\tabularnewline
Nonwhite & 0.11 & 0.31\tabularnewline
Hispanic & 0.06 & 0.23\tabularnewline
Self-pay & 0.22 & 0.41\tabularnewline
Medicare & 0.14 & 0.35\tabularnewline
Medicaid & 0.10 & 0.30\tabularnewline
Private/Commercial & 0.37 & 0.48\tabularnewline
Other government insurance & 0.02 & 0.15\tabularnewline
HMO/prepaid plan & 0.15 & 0.36\tabularnewline
Specialist & 0.68 & 0.46\tabularnewline
Northeast & 0.23 & 0.42\tabularnewline
Midwest & 0.25 & 0.44\tabularnewline
South & 0.28 & 0.45\tabularnewline
West & 0.24 & 0.43\tabularnewline
\bottomrule
\end{longtable}

Notes: Data source: NAMSC91. Sample size is 29,854. Sample size differs
as we use data from a different year. However, the public data from 1989
(the one Hellerstein uses) allow for reproduction of Table 1. For
further information see Table 1 notes in Hellerstein (1998); With the
specifications stated in the manuscript, we cannot reproduce table 1
completely.

Table 2 shows very similar statistics for the patients of the NAMCSd
sample compared to the 1989 data. We observe a smaller sample size in
the 1991 data.

\textbf{Hellerstein Table 2 - Summary Statistics for Patients in NAMCS
Drug Sample}

\begin{longtable}[]{@{}llll@{}}
\toprule
& Mean & Standard Deviation & Proportion Generic\tabularnewline
\midrule
\endhead
Age & 43.79 & 25.13 &\tabularnewline
Female & 0.59 & 0.49 & 0.27\tabularnewline
Nonwhite & 0.12 & 0.32 & 0.34\tabularnewline
Hispanic & 0.06 & 0.24 & 0.33\tabularnewline
Self-Pay & 0.27 & 0.44 & 0.29\tabularnewline
Medicare & 0.15 & 0.36 & 0.21\tabularnewline
Medicaid & 0.11 & 0.31 & 0.32\tabularnewline
Private/Commercial & 0.33 & 0.47 & 0.27\tabularnewline
HMO/prepaid plan & 0.15 & 0.35 & 0.34\tabularnewline
Specialist & 0.60 & 0.49 & 0.26\tabularnewline
Northeast & 0.21 & 0.41 & 0.28\tabularnewline
Midwest & 0.27 & 0.44 & 0.27\tabularnewline
South & 0.29 & 0.46 & 0.25\tabularnewline
West & 0.23 & 0.42 & 0.35\tabularnewline
Full sample & & & 0.28\tabularnewline
\bottomrule
\end{longtable}

Notes: The sample size is 7,715. For further notes see Hellerstein
(1998), Data source: NAMSCd91.

Table 3 shows the absolute number of observations and the share of
generics over all drugs as well as the eight largest drug categories. We
see an overall similar generic share over all drug classes compared to
Hellerstein (\protect\hyperlink{ref-hellerstein_importance_1998}{1998}).
Yet in the drug class pain relief we see an increase of generic share by
about \(9\) percentage points.

\textbf{Hellerstein Table 3 - Frequency of Generic Prescription by Drug
Class}

\begin{longtable}[]{@{}lll@{}}
\toprule
& Observations & \% Generics\tabularnewline
\midrule
\endhead
All drugs & 7715 & 28.37\tabularnewline
& &\tabularnewline
By drug class & &\tabularnewline
Antimicrobials & 2955 & 40.37\tabularnewline
Cardiovascular-renals & 1344 & 16.15\tabularnewline
Central Nervous System & 789 & 25.48\tabularnewline
Hormones/Hormonal mechanisms & 917 & 35.66\tabularnewline
Skin/Mucous membrane & 530 & 9.06\tabularnewline
Ophthalmics & 295 & 13.90\tabularnewline
Pain relief & 634 & 21.29\tabularnewline
Respiratory tract & 251 & 10.76\tabularnewline
\bottomrule
\end{longtable}

\begin{center}\rule{0.5\linewidth}{0.5pt}\end{center}

The distribution of physicians over the different generic prescription
rates (Figure @ref(fig:HellFig1)) is similar to Hellerstein (1998).

\begin{figure}

{\centering \includegraphics[width=1\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/Hellerstein_Fig_1} 

}

\caption{Hellerstein Figure 1 - Distribution of Physician Generic Prescription Rates (Source: NAMSCd91)}\label{fig:HellFigR1}
\end{figure}

\textbf{Figure 2}

\begin{figure}

{\centering \includegraphics[width=1\linewidth]{C:/Users/KFischer/Documents/GitHub/DataLiteracy/images/Hellerstein_Fig_2} 

}

\caption{Hellerstein Figure 2 - Physician decisions by physicians who prescribe a drug to at least six patients (Source: NAMSCd91)}\label{fig:HellFigR2}
\end{figure}

When looking at Figure @ref(fig:HellFig2), we see a decrease from about
90\% to about 50\% in \emph{``only trade-name''} prescriptions by
physicians. This seems to be driven by a rather small increase of
prescription of \emph{``both versions''} and \emph{``only generics''}.

\hypertarget{empirical-analysis}{%
\section{Empirical Analysis}\label{empirical-analysis}}

Keep in mind that due to data restrictions, we were not able to control
for certain covariates that Hellerstein (1998) includes. An example of
such are legislation laws like mandatory or permissive substitution, and
one- or two-line prescription. For this reason, we cannot present all
tables produced by Hellerstein (1998). Given these restrictions, we
cannot run the analysis with the same underlying model specifications.
This restricts us from comparing the results from 1991 and 1989.
However, for the completion of this example we present the results from
Tables 4, 5 and 6:

\textbf{Hellerstein Table 4 - Estimated Coefficients on Demographic
Variables, Geographic Variables, and Average Characteristics for Full
Sample, excluding regional identifiers}

\begin{longtable}[]{@{}lllll@{}}
\toprule
& Random-Effects Probit Coefficient & & Percent change in Generic
&\tabularnewline
\midrule
\endhead
Constant & -0.556** & (-3.17) & &\tabularnewline
Age & -0.002* & (-1.99) & -0.001* & (-1.99)\tabularnewline
Female & -0.112** & (-2.94) & -0.028** & (-2.94)\tabularnewline
Hispanic & 0.025 & (0.28) & 0.006 & (0.28)\tabularnewline
Nonwhite & 0.044 & (0.62) & 0.011 & (0.62)\tabularnewline
Specialist & 0.019 & (0.25) & 0.005 & (0.25)\tabularnewline
Mean age & -0.003 & (-1.10) & -0.001 & (-1.10)\tabularnewline
Percent female & -0.189 & (-1.16) & -0.048 & (-1.16)\tabularnewline
Percent black & 0.075 & (0.41) & 0.019 & (0.41)\tabularnewline
Percent Hispanic & -0.112 & (-0.45) & -0.028 & (-0.45)\tabularnewline
Percent Medicaid & 0.062 & (0.26) & 0.016 & (0.26)\tabularnewline
Percent Medicare & -0.155 & (-0.71) & -0.039 & (-0.71)\tabularnewline
Percent private insured & 0.155 & (1.08) & 0.039 & (1.08)\tabularnewline
Percent HMO/prepaid & 0.054 & (0.30) & 0.014 & (0.30)\tabularnewline
Midwest & -0.141 & (-1.53) & -0.036 & (-1.53)\tabularnewline
South & -0.206* & (-2.28) & -0.052* & (-2.29)\tabularnewline
West & 0.065 & (0.67) & 0.016 & (0.67)\tabularnewline
\bottomrule
\end{longtable}

Notes: \(*p < 0.05, **p < 0.01, ***p < 0.001\); The sample size is
7,715. For further notes see Hellerstein (1998); Data source: NAMSCd91.

Table 5 shows the estimated coefficients for the eight largest drug
classes as well as the \% change in the generic share. The greatest
change compared to Hellerstein (1998) is the change in sign from
positive to negative for cardiovascular/renals, though not significant
in our model.

\textbf{Hellerstein Table 5 - Estimated Coefficients for Drug-Class
Dummy Variable for Full Sample}

\begin{longtable}[]{@{}lllll@{}}
\toprule
& Random-Effects Probit Coefficient & & \% Change in Generic
&\tabularnewline
\midrule
\endhead
main & & & &\tabularnewline
Antimicrobials & 0.628*** & (8.47) & 0.159*** & (8.54)\tabularnewline
Cardiovascular-renals & -0.147 & (-1.71) & -0.0371 &
(-1.71)\tabularnewline
Central Nervous System & 0.0559 & (0.58) & 0.0141 &
(0.58)\tabularnewline
Hormones/Hormonal mechanisms & 0.584*** & (6.92) & 0.148*** &
(6.95)\tabularnewline
Skin/Mucous membrane & -0.731*** & (-6.26) & -0.185*** &
(-6.28)\tabularnewline
Ophthalmics & -0.383* & (-2.47) & -0.0968* & (-2.47)\tabularnewline
Resperatory tract & -0.675*** & (-4.79) & -0.171*** &
(-4.80)\tabularnewline
\bottomrule
\end{longtable}

Notes: \(*p < 0.05, **p < 0.01, ***p < 0.001\); The sample size is
7,715. Omitted category is pain relief. For further notes see
Hellerstein (1998); Data source: NAMSCd91.

\textbf{Hellerstein Table 6 - Tests for Moral Hazard for the Full Sample
Equality of Individual Insurance Variables with Self-Payment
Random-Effects Probit Results}

\begin{longtable}[]{@{}lllllllllllllllll@{}}
\toprule
\begin{minipage}[b]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[b]{0.04\columnwidth}\raggedright
Antimicrobial\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage} & \begin{minipage}[b]{0.04\columnwidth}\raggedright
Cardiovasculars\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage} & \begin{minipage}[b]{0.05\columnwidth}\raggedright
Central Nervous System\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
Hormones\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage} & \begin{minipage}[b]{0.05\columnwidth}\raggedright
Skin/Muchous Membranes\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
Ophthalmics\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage} & \begin{minipage}[b]{0.04\columnwidth}\raggedright
Pain relief\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage} & \begin{minipage}[b]{0.04\columnwidth}\raggedright
Respiratory Tract\strut
\end{minipage} & \begin{minipage}[b]{0.03\columnwidth}\raggedright
\% change\strut
\end{minipage}\tabularnewline
\midrule
\endhead
\begin{minipage}[t]{0.03\columnwidth}\raggedright
Medicaid\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
Coefficient\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.14\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.04\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.00\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.00\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.02\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.00\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.38\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.08\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.03\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.00\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.25\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.05\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.54\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.08\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-1.21\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.09\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
1.12\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
1.13\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.02\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.02\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.08\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.08\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
1.23\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
1.23\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.04\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.04\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.60\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.60\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
1.12\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
1.15\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-1.08\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-1.11\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
Medicare\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
Coefficient\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.11\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.03\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.05\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.01\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
-0.32\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.06\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.42\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.09\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.54\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.05\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.41\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.08\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.08\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.01\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.60\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.05\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.72\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.72\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.25\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.25\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
-1.13\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-1.12\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-1.68\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-1.69\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.89\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.90\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.97\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.97\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.18\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.18\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.67\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.68\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
Private\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
Coefficient\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.00\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.00\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.06\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.01\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
-0.06\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.01\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.16\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.03\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.03\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.00\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.31\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.06\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.18\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.03\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-1.27\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.10\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.01\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.01\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.30\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.30\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
-0.28\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.28\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.75\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.75\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.07\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.07\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.91\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.91\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.51\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.51\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-1.45\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-1.56\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
HMO/Prepaid\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
Coefficient\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.22\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.06\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.14\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.03\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
0.32\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.06\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.33\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.07\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
-0.42\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.04\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.57\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.11\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.28\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.04\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.26\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.02\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.03\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
1.78\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
1.78\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.56\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.56\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
1.04\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
1.05\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-1.09\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-1.09\strut
\end{minipage} & \begin{minipage}[t]{0.05\columnwidth}\raggedright
-0.73\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.73\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.93\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.93\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
0.71\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
0.72\strut
\end{minipage} & \begin{minipage}[t]{0.04\columnwidth}\raggedright
-0.26\strut
\end{minipage} & \begin{minipage}[t]{0.03\columnwidth}\raggedright
-0.25\strut
\end{minipage}\tabularnewline
\bottomrule
\end{longtable}

Notes: see Hellerstein (1998); Data source: NAMSCd91.

\hypertarget{stata-replication-code-of-hellerstein-1998}{%
\chapter{Stata replication code of Hellerstein
(1998)}\label{stata-replication-code-of-hellerstein-1998}}

The following Stata program replicates the empirical analyses of
Hellerstein, Judith K. 1998. ``The Importance of the Physician in the
Generic versus Trade-Name Prescription Decision,'' The RAND Journal of
Economics 29(1):108--36, doi: 10.2307/2555818.

This file contains program code for data preparation, replication of
descriptive tables and figures, and replication of the empirical
analyses and tables. The structure of this file is as follows:

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\tightlist
\item
  Preparing the NAMCS and NAMCSd data (Section @ref(run-study))
\item
  Descriptive statistics using NAMCS and NAMCSd data (Section
  @ref(analyzing))
\item
  Empirical analyses using NAMCSd data (Section @ref(analyzing) and
  Section @ref(report-study))
\end{enumerate}

\hypertarget{A1}{%
\section{Preparing the analysis data set}\label{A1}}

\begin{verbatim}
* Pathing and setup
log close _all
snapshot erase _all
clear all

*storage of NAMCsd raw data
global r                `"  "C:\Users\my name\my project\raw data\" "'

*analysis data
global d                `"  "C:\Users\my name\my project\data\" "'


*results
global tab          `"  "C:\Users\my name\my project\tables\" "'
global fig      `"  "C:\Users\my name\my project\figures\" "'


*Data were downloaded from https://ftp.cdc.gov/pub/Health_Statistics/NCHS/namcs_public_use_files/*
*1991 datasets and documentation: namcs91.exe; namcs91d.exe; namcs91doc.pdf*

*   Preparing NAMCS91:
******************************
use "$r\namcs91_raw.dta" , clear

* 1) Set up relevant dummies
gen female = sex == 1
gen nonwhite = race != 1
gen hispanic = ethnicity == 1
gen northeast = geo_reg == 1
gen midwest = geo_reg == 2
gen south = geo_reg == 3
gen west = geo_reg == 4
//Hellerstein defines specialists as 
//physicians who are not in general practice, family practice, or basic pediatrics.
gen specialist = (phys_special != "GP" & phys_special != "FP" & phys_special != "PD") 
//Medicare patients 
gen temp = selfpay + medicaid + other_gov_ins + private_ins + hmo_pre_paid
replace medicare = 0 if temp != 0  


* 2) Drop observations with unknown payment
gen temp1 = selfpay + medicaid  + medicare + other_gov_ins + private_ins + hmo_pre_paid
keep if temp1 == 1

compress
save "$d\namcs91.dta", replace




*   Preparing NAMCS91d:
****************************
use "$r\namcs91d_raw.dta" , clear


* 1) Removing observations with missing values:
***********************************************
replace generic_id = .b if generic_id == 50000
replace generic_status = .b if generic_status == 3
replace prescription_status = .b if prescription_status == 3
replace composition_status = .b if composition_status == 3 | composition_status == 6

drop if missing(generic_id)|missing(generic_status)|///
  missing(prescription_status)|missing(composition_status)

 
* 2) Creating required variables:
**********************************
** 2.1) Define 8 largest drug classes, see Table 3 and page 79 in Hellerstein's paper
gen major_drug_class = ///
    drug_class == 3 | drug_class == 5 | drug_class == 6 | drug_class == 10 | ///
    drug_class == 12 | drug_class == 15 | drug_class == 17 | drug_class ==  19


** 2.2) Creating some dummies
gen female = sex == 1
gen nonwhite = race != 1
gen hispanic = ethnicity == 1
gen northeast = geo_reg == 1
gen midwest = geo_reg == 2
gen south = geo_reg == 3
gen west = geo_reg == 4

gen specialist = (phys_special != "GP" & phys_special != "FP" & phys_special != "PD") 
gen temp = selfpay + medicaid + private_ins + hmo_pre_paid
replace medicare = 0 if temp != 0

replace generic_status = 0 if generic_status == 2
replace prescription_status = 0 if prescription_status == 2

tab drug_class, gen (drug_class_)
label variable drug_class_3 "Antimicrobial"
label variable drug_class_5 "Cardiovascular-renals"
label variable drug_class_6 "Central Nervous System"
label variable drug_class_10 "Hormones"
label variable drug_class_12 "Skin/Mucous Membranes"
label variable drug_class_15 "Ophthalmics"
label variable drug_class_17 "Pain Relief"
label variable drug_class_19 "Respiratory Test"


** 2.3) Create multisource indicator
*** 2.3.1) Create id for drugs with multiple ingrediants
replace ingredients = generic_id if ingredients == .

*** 2.3.2) Check whether there are both generic and trade-name drugs for each ingredients
bys ingredients: egen counter = mean(generic_status) 
bys ingredients: gen multisource = (counter >0 & counter <1)
drop counter


** 2.4) Set up physician averages
foreach x in age female nonwhite hispanic medicare medicaid hmo_pre_paid private_ins{
    cap: drop mean_`x'
    bys physician_id: egen mean_`x' = mean(`x')
}


* 3) Keeping relevant variables
****************************
//Dropping conditions
keep if prescription_status == 1 & multisource == 1 & major_drug_class == 1 & order_of_drug == 1  
* (selfpay == 1 | medicaid == 1 | private_ins == 1 | hmo_pre_paid == 1 | medicare == 1)
gen temp1 = selfpay + medicaid + medicare + private_ins + hmo_pre_paid
keep if temp1 == 1

keep ///
drug_id drug_name generic_id generic_name generic_status drug_class drug_class_* ingredients ///
age female nonwhite hispanic west northeast midwest south geo_reg specialist mean_* /// 
selfpay medicare medicaid private_ins hmo_pre_paid   ///
geo_reg phys_special phys_type physician_id patient_id

compress
save "$d\namcs91d.dta", replace
\end{verbatim}

\begin{verbatim}
end of do-file
\end{verbatim}

\hypertarget{A2}{%
\section{Descriptive statistics}\label{A2}}

\begin{verbatim}

*   Table 1:
****************

/* Comment:
Information was obtained from the footnote of Table 1, p. 115 of the original study.
The text stats that only uses data without missing values.
This applies to all tables and figures and was done in the initial data preparation.

The footnote defines the dummy variable "specialist":
whether a physician is not a general practice, family practice, or basic pediatrics.
The dummy medicare takes the value of 1 if medicare was the only source of payment.

Observations of patient visits in which the patient was not charged were excluded.
*/
  
  
use "$d\namcs91.dta", clear

qui eststo table1: estpost summarize age female nonwhite hispanic selfpay medicare medicaid ///
private_ins other_gov_ins  hmo_pre_paid specialist northeast midwest south west

esttab table1 using "$tab\Table_1.rtf", replace  ///
title("Summary Statistics for Overall NAMCS Patient Sample") ///
cells ("mean(fmt(%12.2f)) sd(fmt(%12.2f))") nonumber noobs ///
coeflabels(age "Age" female "Female" nonwhite "Nonwhite" hispanic "Hispanic" ///
selfpay "Self-pay" medicare "Medicare" medicaid "Medicaid" private_ins "Private/commercial" ///
other_gov_ins "Other government insurance" hmo_pre_paid "HMO/prepaid plan" ///
  specialist "Specialist" ///
northeast "Northeast" midwest "Midwest" south "South" west "West" ) ///
addnote("Notes: Sample size is 32,407. For further notes see table 1 notes in Hellerstein (1998); ///
        Sample size differs as data from different years is used" "Data source: NAMSC91")




*   Table 2:
****************

/* Comment:
Variables and data preparing processes equivalent to Table 1.

Create a matrix resembling the table and store each value in its respective cell.
*/
use "$d\namcs91d.dta", clear


* 1) Saving all values in locals:
**********************************
* For all rows besides the last one
foreach x in age female nonwhite hispanic selfpay medicare medicaid  private_ins hmo_pre_paid specialist northeast midwest south west {
    
    * Computing mean and sd
    qui: sum `x'
    local `x'_m = r(mean)
    local `x'_std = r(sd)
    
    * Computing the share of generics for all rows exept for the row age
    if "`x'" != "age"{
        qui: sum  generic_status if `x' == 1
        local `x'_share = r(mean)
    }
    }
    
* Last row (Share of generics in the full sample)
qui: sum generic_status
local fullsample_share = r(mean)
    

* 2) Filling a matrix with the locals:
***************************************
mat input table2 = ( /// 
`age_m', `age_std' , . \ ///
`female_m', `female_std', `female_share' \ ///
`nonwhite_m', `nonwhite_std', `nonwhite_share' \ ///
`hispanic_m', `hispanic_std', `hispanic_share' \ ///
`selfpay_m', `selfpay_std', `selfpay_share' \ ///
`medicare_m', `medicare_std', `medicare_share' \ ///
`medicaid_m', `medicaid_std', `medicaid_share' \ ///
`private_ins_m', `private_ins_std', `private_ins_share' \ ///
`hmo_pre_paid_m', `hmo_pre_paid_std', `hmo_pre_paid_share' \ ///
`specialist_m', `specialist_std', `specialist_share' \ ///
`northeast_m', `northeast_std', `northeast_share' \ ///
`midwest_m', `midwest_std', `midwest_share' \ ///
`south_m', `south_std', `south_share' \ ///
`west_m', `west_std', `west_share' \ ///
. , . , `fullsample_share' ///
 )

 
* 3) Labelling and exporting:
**************************************
matrix rownames table2 = ///
"Age" "Female" "Nonwhite" "Hispanic" "Self-Pay" "Medicare" "Medicaid" "Private/Commercial" ///
"HMO/prepaid plan" ///
"Specialist" "Northeast" "Midwest" "South" "West" "Full sample"

matrix colnames table2 = "Mean" "Standard Deviation" "Proportion Generic"

putexcel set "$tab\Table_2.xlsx", replace
putexcel A1 = matrix(table2 ), names


*   Table 3:
****************
use "$d\namcs91d.dta", clear
return clear
ereturn clear

* Turn decimal numbers into percentage
gen All_drugs = generic_status * 100

* generic share for all drugs
eststo t10: quietly estpost tabstat All_drugs, ///
statistics(mean N) columns(statistics) listwise

* generic share by drug class
eststo t20: quietly estpost tabstat All_drugs, by(drug_class) ///
statistics(mean N) columns(statistics) listwise notot

esttab t10 t20 using "$tab\Table_3.rtf", replace ///
cells("count(fmt(%12.0f)) mean(fmt(%12.2f))") ///
title("Table 3 - Frequency of Generic Prescription by Drug Class") ///
collabels("Observations" "% Generics") noobs nonumber gaps refcat(3 "By drug class" , nolabel) ///
coeflabels(generic "All drugs" 3 "Antimicrobials" 5 "Cardiovascular-renals" ///
 6 "Central Nervous System" 10 "Hormones/Hormonal mechanisms" ///
 12 "Skin/Mucous membrane" 15 "Ophthalmics" 17 "Pain relief" 19 "Resperatory tract") 




*   Figure 1:
*****************
/* Comment:
Visualizations of kernel densities vary depending on the specifications. 
Two parameters define the density function: Bandwidth and whether/how to round the data.
Hellerstein does not provide information about the density function.
We  visually rule out that she rounds to the first decimal place.
There are fluctuations between the first decimal places.
Rounding to the third or higher decimal places produces much noisier curves.
Hence, we assume that she rounded to the second decimal place.
For the bandwidth and density function, there are no obvious clues.
That the reproduction relies on visual approximation of the original figure.
*/


* 1) Estimate the mean share of prescribed generics per physician
bys physician_id: egen temp2 = mean(generic_status)
gen generic_share = round(temp2, .01) 


* 2) Collapse the data so that one observation per physician remains
duplicates drop physician_id, force


* 3) Recreate Figure 1
set scheme  s1manual
twoway kdensity generic_share, range(0 1) bw( 0.02) kernel(bi)  ///
xtitle("Physician generic prescription rates") ytitle("Percent of physicians") ///
xlabel(0 (0.1) 1) lc(black)

graph export "$fig\Figure_1.png", replace



*   Figure 2:
*****************
use "$d\namcs91d.dta", clear

/* Comment:
The figure uses observations of drugs with > 6 prescriptions by a single physician. 
158 unique physicians remain in Hellerstein (1998).
We are left with 122 physicians (see p. 116 first paragraph).
*/


* 1) Apply dropping conditions
bys physician_id ingredient : gen temp = _N
drop if temp < 6
* Check the number of remaining physicians. 158 in Hellerstein
qui: tab physician_id
di r(r)


* 2) Create the categories for the bars
** 2.1) Avg generic prescription rate for each per physician
bys physician_id ingredients: egen temp2 = mean(generic_status) 

 * 2.2) Use the share to set up the groups
gen counter = .
replace counter = 0 if temp2 == 0 /* Never generic */
replace counter = 1 if temp2 > 0 & temp2 < 1 /* Sometimes */
replace counter = 2 if temp2 == 1 /* Always */

label define l 0 "Only trade names" 1 "Both versions" 2 "Only generics"
label values counter l


* 3) Collapse the data so that one observation per physician remains
duplicates drop physician_id, force


* 4) Recreating the figure
set scheme  s1manual
graph bar (count), over(counter) ///
ytitle("") intensity(60) lintensity(100) bar(1, color("black") fcolor("gs5")) ylab(, nogrid)

graph export "$fig\Figure_2.png", replace
\end{verbatim}

\begin{verbatim}
invalid 'C' 
r(198);

end of do-file
r(198);
\end{verbatim}

\hypertarget{A3}{%
\section{Empirical analyses and tables}\label{A3}}

\begin{verbatim}

* Setting up the regression input, equivalent to the notation in the paper

use "$d\namcs91d.dta", clear
xtset physician_id



gen G = generic_status

/* drug classes */
global C drug_class_3 drug_class_5 drug_class_6 drug_class_10 drug_class_12 drug_class_15 drug_class_19     

/* patient demographics */
global X age female hispanic nonwhite                                       

/* insurance */
global P medicare medicaid hmo_pre_paid private_ins                             

/* is phys a specialist */
global S specialist                                             

/* region */
global R midwest south west                                         

/* patient avgs */
global X_dash mean_age mean_female mean_nonwhite mean_hispanic                          

/* insurance avgs */
global P_dash mean_medicaid mean_medicare mean_private_ins mean_hmo_pre_paid                    

* M and T are not included due to missing state id




*   Table 4:
****************
return clear
ereturn clear
eststo clear

eststo table4: xtprobit G $C $X $P $S $X_dash $P_dash $R, re
eststo marginstable4: margins, dydx( $X $S $X_dash $P_dash $R) post

*Reporting Table 4
esttab table4 marginstable4 using "$tab\Table-4.rtf", replace wide ///
keep(_cons $X $S $X_dash $P_dash $R) stats(rho) noobs b(3) order(_cons) ///
coeflabels(_cons "Constant" age "Age" female "Female" nonwhite "Nonwhite" hispanic "Hispanic" ///
              specialist "Specialist" mean_age "Mean age" /// 
mean_female "Percent female" mean_nonwhite "Percent black" ///
  mean_hispanic "Percent Hispanic" mean_medicaid "Percent Medicaid" mean_medicare ///
"Percent Medicare" mean_private_ins "Percent private insured" ///
  mean_hmo_pre_paid "Percent HMO/prepaid"  northeast "Northeast" midwest ///
"Midwest" south "South" west "West") ///
  mtitles("Random-Effects Probit Coefficient" "% Change in Generic") nonumber addnote("Datasource: NAMSC91") 




*   Table 5:
****************
return clear
ereturn clear
eststo clear

eststo table5:   xtprobit G $C $X $P $S $R $X_dash $P_dash, re
eststo marginstable5: margins, dydx($C) post

*Reporting Table 5
esttab table5 marginstable5 using "$tab\Table-5.rtf", replace noobs wide keep($C) nonumber ///
coeflabels(drug_class_1 "Antimicrobials" drug_class_2 "Cardiovascular-renals"///
             drug_class_3 "Central Nervous System" drug_class_4 ///
"Hormones/Hormonal mechanisms" drug_class_5 "Skin/Mucous membrane" drug_class_6 "Ophthalmics" drug_class_8 "Resperatory tract") ///
addnote("Notes: The ommitted drug category is pain relief" "Datasource: NAMSC91") mtitles("Random-Effects Probit Coefficient" "% Change in Generic") 


*   Table 6:
****************
return clear
ereturn clear
eststo clear

foreach x in 3 5 6 10 12 15 17 19 {

* Estimating and saving the coefs
eststo c_`x': quietly xtprobit G $X $P $S $R $X_dash $P_dash  if drug_class_`x' == 1, re
* Estimating and saving the marginal effects (AME, see table footer)
eststo m_`x': qui margins, dydx($P) post
}


esttab c_3 m_3 c_5 m_5 c_6 m_6 c_10 m_10 c_12 m_12 c_15 m_15 c_17 m_17 c_19 m_19 using "$tab\Table6.rtf", replace ///
nostar nopar  keep($P)  noobs b(2)  order(medicaid medicare private_ins hmo_pre_paid) ///
refcat(medicare "Medicare" medicaid "Medicaid" hmo_pre_paid "HMO/Prepaid" private_ins "Private", nolabel) ///
coeflabels(medicare "Coefficient" medicaid "Coefficient" hmo_pre_paid "Coefficient" private_ins "Coefficient") ///
mtitle("Antimicrobial" "% change" "Cardiovasculars" "% change" "Central Nervous System" "% change" "Hormones" "% change" "Skin/Muchous Membranes" "% change" "Ophthalmics" ///
"% change" "Pain relief" "% change" "Respiratory Tract" "% change" ) nonumbers eqlabels(none) collabels(none) nonumbers compress


* Tables 7, 8 and 9 are not reproducible due to missing state id in the publicly available datasets
\end{verbatim}

\begin{verbatim}
invalid 'C' 
r(198);

end of do-file
r(198);
\end{verbatim}

\hypertarget{refs}{}
\leavevmode\hypertarget{ref-abadie_econometric_2018}{}%
Abadie, Alberto, and Matias D. Cattaneo. 2018. ``Econometric Methods for
Program Evaluation.'' \emph{Annual Review of Economics} 10 (1):
465--503. \url{https://doi.org/10.1146/annurev-economics-080217-053402}.

\leavevmode\hypertarget{ref-bezjak_open_2018}{}%
Bezjak, Sonja, April Clyburne-Sherin, Philipp Conzett, Pedro Fernandes,
Edit Görögh, Kerstin Helbig, Bianca Kramer, et al. 2018. \emph{Open
Science Training Handbook}. Zenodo.
\url{https://doi.org/10.5281/ZENODO.1212496}.

\leavevmode\hypertarget{ref-bollen_social_2015}{}%
Bollen, K., J. T. Cacioppo, R. M. Kaplan, Krosnick J. A., and J. L.
Olds. 2015. ``Social, Behavioral, and Economic Sciences Perspectives on
Robust and Reliable Science.'' National Science Foundation.
\url{https://www.nsf.gov/sbe/AC_Materials/SBE_Robust_and_Reliable_Research_Report.pdf}.

\leavevmode\hypertarget{ref-cameron_microeconometrics_2005}{}%
Cameron, Adrian Colin, and Pravin K. Trivedi. 2005.
\emph{Microeconometrics: Methods and Applications}. Nachdr. Cambridge:
Cambridge Univ. Press.

\leavevmode\hypertarget{ref-cochrane_writing_2005}{}%
Cochrane, John H. 2005. ``Writing Tips for Ph. D. Students,'' June, 13.
\url{http://gsbwww.uchicago.edu/fac/john.cochrane/research/Papers/}.

\leavevmode\hypertarget{ref-danzon_cross-national_2011}{}%
Danzon, Patricia M., and Michael F. Furukawa. 2011. ``Cross-National
Evidence on Generic Pharmaceuticals: Pharmacy Vs. Physician-Driven
Markets.'' \emph{NBER Working Paper 17226}, July,
http://www.nber.org/papers/w17226.
\url{http://www.nber.org/papers/w17226}.

\leavevmode\hypertarget{ref-noauthor_developing_2019}{}%
``Developing Strong Research Questions Criteria and Examples.'' 2019.
\emph{Scribbr}.
\url{https://www.scribbr.com/research-process/research-questions/}.

\leavevmode\hypertarget{ref-dranove_medicaid_1989}{}%
Dranove, David. 1989. ``Medicaid Drug Formulary Restrictions.''
\emph{The Journal of Law and Economics} 32 (1): 143--62.
\url{https://doi.org/10.1086/467172}.

\leavevmode\hypertarget{ref-dudenhefer_guide_2014}{}%
Dudenhefer, Paul. 2014. \emph{Guide to Writing in Economics}. Duke
University.

\leavevmode\hypertarget{ref-dunne_review_2013}{}%
Dunne, Suzanne, Bill Shannon, Colum Dunne, and Walter Cullen. 2013. ``A
Review of the Differences and Similarities Between Generic Drugs and
Their Originator Counterparts, Including Economic Benefits Associated
with Usage of Generic Medicines, Using Ireland as a Case Study.''
\emph{BMC Pharmacology \& Toxicology} 14 (January): 1.
\url{https://doi.org/10.1186/2050-6511-14-1}.

\leavevmode\hypertarget{ref-eriksson_secondary_2016}{}%
Eriksson, Irene, and Luisa Ibáñez. 2016. ``Secondary Data Sources for
Drug Utilization Research.'' In \emph{Drug Utilization Research},
39--48. John Wiley \& Sons, Ltd.
\url{https://doi.org/10.1002/9781118949740.ch4}.

\leavevmode\hypertarget{ref-fitchett_quantitative_2017}{}%
Fitchett, Paul G., and Tina L. Heafner. 2017. ``Quantitative Research
and Large-Scale Secondary Analysis in Social Studies.'' In \emph{The
Wiley Handbook of Social Studies Research}, 68--94. John Wiley \& Sons,
Ltd. \url{https://doi.org/10.1002/9781118768747.ch4}.

\leavevmode\hypertarget{ref-hair_nature_2019}{}%
Hair, Joe F., Michael Page, and Niek Brunsveld. 2019. ``The Nature and
Sources of Secondary Business Data.'' In \emph{Essentials of Business
Research Methods}, 4th ed. Routledge.

\leavevmode\hypertarget{ref-hall_how_2013}{}%
Hall, George M., ed. 2013. \emph{How to Write a Paper}. 5th ed.
Chichester, West Sussex: Wiley-Blackwell.

\leavevmode\hypertarget{ref-hellerstein_importance_1998}{}%
Hellerstein, Judith K. 1998. ``The Importance of the Physician in the
Generic Versus Trade-Name Prescription Decision.'' \emph{The RAND
Journal of Economics} 29 (1): 108--36.
\url{https://doi.org/10.2307/2555818}.

\leavevmode\hypertarget{ref-noauthor_how_2019}{}%
``How to Write a Strong Hypothesis Steps and Examples.'' 2019.
\emph{Scribbr}.
\url{https://www.scribbr.com/research-process/hypotheses/}.

\leavevmode\hypertarget{ref-huntington-klein_chapter_nodate}{}%
Huntington-Klein, Nick. n.d. \emph{Chapter 16 - Fixed Effects the
Effect}. Accessed March 1, 2022.
\url{https://theeffectbook.net/ch-FixedEffects.html}.

\leavevmode\hypertarget{ref-huschka_why_2013}{}%
Huschka, Denis. 2013. ``Why Should We Share Our Data, How Can It Be
Organized, and What Are the Challenges Ahead?'' \emph{SSRN Electronic
Journal}. \url{https://doi.org/10.2139/ssrn.2272028}.

\leavevmode\hypertarget{ref-kesselheim_clinical_2008}{}%
Kesselheim, Aaron S. 2008. ``Clinical Equivalence of Generic and
Brand-Name Drugs Used in Cardiovascular Disease: A Systematic Review and
Meta-Analysis.'' \emph{JAMA} 300 (21): 2514.
\url{https://doi.org/10.1001/jama.2008.758}.

\leavevmode\hypertarget{ref-lewbel_identification_2019}{}%
Lewbel, Arthur. 2019. ``The Identification Zoo: Meanings of
Identification in Econometrics.'' \emph{Journal of Economic Literature}
57 (4): 835--903. \url{https://doi.org/10.1257/jel.20181361}.

\leavevmode\hypertarget{ref-matthay_alternative_2020}{}%
Matthay, Ellicott C., Erin Hagan, Laura M. Gottlieb, May Lynn Tan, David
Vlahov, Nancy E. Adler, and M. Maria Glymour. 2020. ``Alternative Causal
Inference Methods in Population Health Research: Evaluating Tradeoffs
and Triangulating Evidence.'' \emph{SSM - Population Health} 10 (April):
100526. \url{https://doi.org/10.1016/j.ssmph.2019.100526}.

\leavevmode\hypertarget{ref-mccloskey_economical_2019}{}%
McCloskey, Deirdre N., and Stephen T. Ziliak. 2019. \emph{Economical
Writing, Third Edition: Thirty-Five Rules for Clear and Persuasive
Prose}. Third Edition. Chicago ; London: University of Chicago Press.

\leavevmode\hypertarget{ref-meyer_whats_2017}{}%
Meyer, Klaus E., Arjen van Witteloostuijn, and Sjoerd Beugelsdijk. 2017.
``What's in a P? Reassessing Best Practices for Conducting and Reporting
Hypothesis-Testing Research.'' \emph{Journal of International Business
Studies} 48 (5): 535--51.
\url{https://doi.org/10.1057/s41267-017-0078-8}.

\leavevmode\hypertarget{ref-munafo_manifesto_2017}{}%
Munafò, Marcus R., Brian A. Nosek, Dorothy V. M. Bishop, Katherine S.
Button, Christopher D. Chambers, Nathalie Percie du Sert, Uri Simonsohn,
Eric-Jan Wagenmakers, Jennifer J. Ware, and John P. A. Ioannidis. 2017.
``A Manifesto for Reproducible Science.'' \emph{Nature Human Behaviour}
1 (1): 1--9. \url{https://doi.org/10.1038/s41562-016-0021}.

\leavevmode\hypertarget{ref-orozco_how_2020}{}%
Orozco, Valérie, Christophe Bontemps, Elise Maigné, Virginie Piguet,
Annie Hofstetter, Anne Lacroix, Fabrice Levert, and Jean-Marc Rousselle.
2020. ``How to Make a Pie: Reproducible Research for Empirical Economics
and Econometrics.'' \emph{Journal of Economic Surveys} 34 (5): 1134--69.
\url{https://doi.org/https://doi.org/10.1111/joes.12389}.

\leavevmode\hypertarget{ref-pearl_causality_2009}{}%
Pearl, Judea. 2009. \emph{Causality}. Cambridge: Cambridge University
Press. \url{https://doi.org/10.1017/CBO9780511803161}.

\leavevmode\hypertarget{ref-pearl_causal_2016}{}%
Pearl, Judea, Madelyn Glymour, and Nicholas P. Jewell. 2016.
\emph{Causal Inference in Statistics: A Primer}. Chichester, West
Sussex: Wiley.

\leavevmode\hypertarget{ref-pirro_how_2019}{}%
Pirro, Laura. 2019. ``How Agile Project Management Can Work for Your
Research.'' \emph{Nature}, April.
\url{https://doi.org/10.1038/d41586-019-01184-9}.

\leavevmode\hypertarget{ref-pischke_how_2012}{}%
Pischke, Steve. 2012. ``How to Get Started on Research in Economics?''
\url{http://econ.lse.ac.uk/staff/spischke/phds/get_started.pdf}.

\leavevmode\hypertarget{ref-plamen_writing_2020}{}%
Plamen, Nikolov. 2020. ``Writing Tips for Economics Research Papers.''
\emph{MPRA Paper}, no. No. 105088.
\url{https://mpra.ub.uni-muenchen.de/105088/}.

\leavevmode\hypertarget{ref-santiago-lopez_six_2019}{}%
Santiago-Lopez, Angel. 2019. ``Six Project-Management Tips for Your
PhD.'' \emph{Nature} 573 (7772): 153--53.
\url{https://doi.org/10.1038/d41586-018-07860-6}.

\leavevmode\hypertarget{ref-schilbach_5_2019}{}%
Schilbach, Frank. 2019. ``5 Steps Toward a Paper.'' MIT 14.192 guest
lecture.
\url{https://www.dropbox.com/s/q7wjaidl5w91srt/Guest\%20lecture\%20FS.pdf?dl=0}.

\leavevmode\hypertarget{ref-statista_prescription_nodate}{}%
Statista. n.d. ``Prescription Drug Spending in U.S. 1960-2020.''
\emph{Statista}. Accessed March 1, 2022.
\url{https://www.statista.com/statistics/184914/prescription-drug-expenditures-in-the-us-since-1960/}.

\leavevmode\hypertarget{ref-varian_how_2016}{}%
Varian, Hal R. 2016. ``How to Build an Economic Model in Your Spare
Time.'' \emph{The American Economist} 61 (1): 81--90.
\url{https://doi.org/10.1177/0569434515627089}.

\leavevmode\hypertarget{ref-vilhuber_reproducibility_2020}{}%
Vilhuber, Lars. 2020. ``Reproducibility and Replicability in
Economics.'' \emph{Harvard Data Science Review} 2 (4).
\url{https://doi.org/10.1162/99608f92.4f6b9e67}.

\backmatter
\end{document}
